Next Article in Journal
The Insulin Receptor Mediates Insulin’s Early Plasma Clearance by Liver, Muscle, and Kidney
Next Article in Special Issue
Effect of Methionine Restriction on Aging: Its Relationship to Oxidative Stress
Previous Article in Journal
Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells
Previous Article in Special Issue
Antioxidant/Anti-Inflammatory Effects of Caloric Restriction in an Aged and Obese Rat Model: The Role of Adiponectin
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Can Exercise-Induced Muscle Damage Be a Good Model for the Investigation of the Anti-Inflammatory Properties of Diet in Humans?

by
Spyridon Methenitis
1,
Ioanna Stergiou
2,3,
Smaragdi Antonopoulou
3 and
Tzortzis Nomikos
3,*
1
Sports Performance Laboratory, School of Physical Education & Sports Science, National and Kapodistrian University of Athens, 17237 Athens, Greece
2
Bioiatriki, Ergometric and Nutrition Center, 11526 Athens, Greece
3
Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, 17671 Athens, Greece
*
Author to whom correspondence should be addressed.
Biomedicines 2021, 9(1), 36; https://doi.org/10.3390/biomedicines9010036
Submission received: 9 November 2020 / Revised: 23 December 2020 / Accepted: 29 December 2020 / Published: 5 January 2021

Abstract

:
Subclinical, low-grade, inflammation is one of the main pathophysiological mechanisms underlying the majority of chronic and non-communicable diseases. Several methodological approaches have been applied for the assessment of the anti-inflammatory properties of nutrition, however, their impact in human body remains uncertain, because of the fact that the majority of the studies reporting anti-inflammatory effect of dietary patterns, have been performed under laboratory settings and/or in animal models. Thus, the extrapolation of these results to humans is risky. It is therefore obvious that the development of an inflammatory model in humans, by which we could induce inflammatory responses to humans in a regulated, specific, and non-harmful way, could greatly facilitate the estimation of the anti-inflammatory properties of diet in a more physiological way and mechanistically relevant way. We believe that exercise-induced muscle damage (EIMD) could serve as such a model, either in studies investigating the homeostatic responses of individuals under inflammatory stimuli or for the estimation of the anti-inflammatory or pro-inflammatory potential of dietary patterns, foods, supplements, nutrients, or phytochemicals. Thus, in this review we discuss the possibility of exercise-induced muscle damage being an inflammation model suitable for the assessment of the anti-inflammatory properties of diet in humans.

1. Introduction

Subclinical, low-grade, inflammation is one of the main pathophysiological mechanisms underlying the majority of chronic and non-communicable diseases [1,2,3,4,5]. It is therefore obvious that non-pharmacological interventions, such as dietary ones, aiming to modulate immune system, without compromising it, could serve as efficient ways of prevention while at the same time they could act complementarily to standard medication. In the last two decades, several dietary patterns different food items, phytochemicals, nutraceuticals, and supplements are promoted with the claim of possessing anti-inflammatory properties [6,7,8,9,10,11]. However, the impact of the above interventions in the immune system of humans remains uncertain since the majority of the studies have been performed under laboratory settings (e.g., cell culture and/or animal testing). Thus, the extrapolation of these results to humans is risky [12,13]. In addition, the majority of the clinical trials, exploring the “anti-inflammatory” effect of dietary/supplementation patterns on human subjects, assess their effectiveness based on their impact on a limited panel of inflammatory biochemical markers, mainly under controlled, fasted, non-stressed conditions. According to this, it will be of interest if we could assess the pro-inflammatory and/or anti-inflammatory profile of different dietary interventions, by developing inflammatory models, in humans, which could induce a transient inflammatory response to volunteers in a regulated and predicted fashion. The development of inflammatory conditions in humans, could be achieved, either by pharmaceutical or medical interventions, or by intentional injuries such as mechanical trauma, toxins, unhealthy lifestyles, and burns. Of course, the majority of these approaches have several ethical restraints that impair the development of such models. In contrast, ethical, controlled, and well-established models, to induce transient inflammation in humans, are certain exercise/training modalities, which are known to induce elevations of inflammatory-, oxidative stress-, and muscle-damage-related blood markers [14,15], impair clinical phenotypes, and alter metabolic procedures [16,17,18,19]. In this review article we discuss the possibility of exercise-induced muscle damage (EIMD) being a model of acute inflammation suitable for the assessment of the anti-inflammatory properties of diet in humans.

2. The Protective Anti-Inflammatory Role of Nutrition in Chronic Diseases

The inflammatory responses are integral parts of the normal innate immune response conferring protection to infection and initiating mechanisms of repair and regeneration of damaged tissues [20,21]. Under acute inflammatory conditions, recognition receptors activate several signaling cascades, leading to the release of pro- and anti-inflammatory mediators, which orchestrate the recruitment of neutrophils and monocytes/macrophages to the damaged tissues while at the same time initiate the lysis of inflammation and the repair of tissue [20,21,22,23]. However, even a low to moderate chronic activation of inflammatory mechanisms induced either from long-term, persistent infections, autoimmune diseases, and/or increased daily inflammatory insults due to lifestyle (obesity, sedentary lifestyle, smoking, stress) and dietary habits (dense meals rich in simple sugars, trans fatty acids, advanced glycation end-products) overwhelms the anti-inflammatory processes of the immune system resulting in a chronic, sub-clinical inflammation [2,6,24,25,26,27,28,29,30]. The biochemical phenotype of this condition is mildly elevated levels of inflammatory mediators in the circulation. For example, C-reactive protein (CRP) levels are raised 2–3 fold under low-grade inflammation while those levels can be increased up to 10–1000 times in acute inflammation [31].
It is well documented that a subclinical activation of the inflammatory mechanisms may be a predisposing risk factor for non-communicable diseases such as cardiovascular disease, cancer, metabolic syndrome, diabetes, depression, dementia, and biological aging in general [1,2,3,4,25,32,33,34,35,36]. Actually, subclinical inflammation seems to underlie the link between unhealthy lifestyle with the pathogenesis of chronic diseases [2,23,29]. Taking into account the linear relationship between the levels of subclinical inflammation markers (e.g., CRP) and the risk for chronic diseases it is obvious that even a small attenuation of subclinical inflammation by lifestyle changes may confer protection against those diseases [7,36,37,38,39]. Therefore, dietary interventions targeting to reduce inflammation seem to be an efficient way of prevention for diseases with a chronic inflammatory background [7,9,10,30,40,41,42,43].
It is now known that prudent dietary patterns, such as the Mediterranean Diet [7,8,39,44,45] and macro/micro-nutrients, have a strong protective effect against non-communicable diseases, with a strong inflammatory profile [10,30,40,41,42,43]. For the majority of these studies, the assessment of the anti-inflammatory properties of diet was based on the measurement of few classical circulating markers (CRP, IL-6, TNFα). On the other hand, a plethora of microNutrients, phytochemicals, and supplements failed to attenuate inflammation in humans, despite their strong anti-inflammatory actions in cellular and animal studies [12,13,40,46]. The main reason for this discrepancy is the complexity of the pathophysiology of inflammation in humans which can be poorly replicated by animals or cell culture models. Taking into consideration the controversy between animal and human experimentation it seems that the development of more realistic, novel methodological tools for the study of inflammation directly to humans is highly important.

3. The Development of Inflammation Models in Humans Would Greatly Facilitate the Assessment of the Anti-Inflammatory Properties of Nutrition

Several methodological approaches have been applied for the assessment of the anti-inflammatory properties of nutrition. The majority of them is based on cellular and animal models of inflammation. Cellular models of inflammation include LPS-induced secretion of cytokines, expression of adhesion molecules in the surface of cells, phagocytosis activity, natural killer cells lysing capability against cancer cells etc. Cell-based assays were mainly utilized for the identification of the anti-inflammatory properties of isolated nutrients, extracts, and phytochemicals. Despite their usefulness for screening purposes and mechanistic studies the results of those studies cannot be extrapolated directly to humans [12,13,40,46]. The active dietary ingredients, in vivo, are found in much lower concentrations and in a more complex environment than those used in the cellular studies and in structural forms which may differ from the initial structures in foods due to in vivo metabolism [47].
The rapid growth of genetic engineering enabled the development of a plethora of animal models of inflammation by which the anti-inflammatory properties of diet could be assessed, in a more physiological way. Moreover, animal experiments provide wider access to the immune system (thymus, lymph nodes, bone marrow, peritoneal cavity). However, after many years of studying and working with animals in biomedical research, ethical issues have emerged concerning the reproducibility of animal models and their relevance with human inflammatory diseases [12,13,40,46,48]. The results from animal experiments cannot be easily extrapolated to humans because of the biological differences between species [12,13,40,46,48]. Over and above that, many studies in animal models are of poor methodological design exposing patients to unnecessary risk and wasting research funds. This is justified by the discrepancy between the outcomes of animal experiments and clinical trials [12,46,48].
The majority of human studies, investigating the association between diet and inflammation, are cross-sectional and prospective epidemiological studies [3,49,50,51,52,53,54]. The outcomes are based on the measurement of a small panel of soluble inflammatory mediators and hematological indices which by no way give a holistic view of the inflammatory system while at the same time is questionable whether the tools of the nutritional assessment are reliable to estimate dietary intakes accurately [3,49,50,51,52,53,54]. Randomized dietary interventions are the gold standard of human experimentation and several dietary interventions have been so far tried to assess the ability of dietary patterns, supplements, food items, and nutrients to modulate subclinical inflammation [3,49,50,51,52,53,54]. Although this is the best experimental approach so far, randomized dietary interventions lack mechanistic information since the interpretation of the results is based on the comparison of a limited panel of inflammatory indices, measured under static conditions in biological fluids, before and after the intervention. Even if a dietary intervention is able to favorably modulate inflammatory indices this could be the indirect result of diet on other risk factors of subclinical inflammation (e.g., weight loss) rather than a direct involvement to inflammatory mechanisms. In addition, most dietary intervention studies do not assess clinical phenotypes of inflammation either because they do not exist or they are difficult to be estimated in humans. Finally, most dietary intervention studies measure inflammatory mediators, at one-time point, under fasting and resting conditions which does not allow the assessment of intervention’s ability to modulate the response (plasticity) of the immune system under real inflammatory insults. It is therefore obvious that the development of an inflammatory model in humans, by which we could induce inflammatory responses to humans in a regulated, specific, and non-harmful way, could greatly facilitate the estimation of the anti-inflammatory properties of diet in a more physiological and mechanistically relevant way. We believe that exercise-induced muscle damage could serve as such a model, at least for acute/transient, self-limited inflammatory pathophysiological conditions. Considering this, several excellent studies, mainly coming from the field of sports nutrition, have already proven the ability of dietary interventions (protein supplements, phytochemicals, omega-3 fatty acids, BCAA) to diminish EIMD-induced inflammation, and thus to provide positive effects on muscle morphology/function, athletic performance and recovery, establishing the utility of EIMD as a suitable inflammatory model (for example: [5,14,15,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70]).

4. Exercise-Induced Muscle Damage’s Prototypic Inflammatory Responses in Muscle Tissue

EIMD is a phenomenon that occurs either after a prolonged unaccustomed exercise, or after a very intense, high-demanding exercise (high intensity, long duration, high volume, high frequent, or combination of these), as a consequence of the very high mechanical and metabolic demands during the exercise [14,15,55,65,70,71,72,73,74,75]. EIMD is classified as a grade 1 muscular injury, characterized by minor ultrastructural muscle disruptions without a permanent defect, such as structural disruption of sarcomeres, disturbed excitation-contraction coupling and calcium signaling, and extended muscle protein degradation [14,15,55,71,72,73,74,75,76,77,78,79,80,81,82]. Although the pathology of EIMD is usually subclinical, the perceived sensation may vary from mild muscle stiffness to exhausting pain and a temporary reduction in both maximum strength and range of motion until several days after the stimuli [15,83,84]. It is also usually accompanied by sensitivity, swelling, or stiffness during palpation or motion of the damaged muscle, a process which is associated with delayed onset muscle soreness (DOMS) [73,85]. However, this inflammatory environment as a cellular response of muscle tissue damage is of high importance for the proper muscle tissue’s repair and regeneration [15,71,76,78,82,85].
The type of exercise and the type of muscle contractions applied are crucial determinants of the damaging and inflammatory responses. It is well established that the eccentric exercise, which involves only lengthening muscle actions, could lead to extensive EIMD and inflammation [15,55,72,74,84,86,87,88]. During eccentric exercises (isokinetic, downhill running, descending the stairs or a box) muscles are forced to lengthen, when the external forces (external weights, gravity, body weight) acting on them are greater than the forces that muscles can produce. This leads to an overstretching of sarcomeres, beyond their normal lengths [63,72,74,84,88,89,90,91,92,93,94,95,96,97,98,99]. During extensive sarcomere lengthening, there is a decreased overlapping of actin-myosin filaments, leading to a decreased number of active cross-bridge attachments, and thus to a decreased capability for active force generation [55,72,73,74,84,90,93,97,98,99,100,101,102,103]. In addition, although during eccentric contractions, muscles are capable to produce or absorb greater forces, as it reveals from the force–velocity curve [104], the motor units recruitment order is different between eccentric contractions and concentric, with type II muscle fibers to be recruited from the onset of muscle contraction even if the activation of muscle fibers is reduced compared to when the muscle performs maximal concentric contractions [105,106,107]. Thus, due to the fewer motor units that are recruited during eccentric contractions, as well as to the stretched and overstretched sarcomeres, where there is a reduced overlap of myosin and actin filaments, muscles are forced to overcome the external loads in a very adverse mechanical environment, in the same time that passive forces are dramatically increased leading to sarcomeres’ over-straining and thus a disruption of the sarcomere, probably due to titin-stretch-induced damage [74,84,90,97,98,99,102,108,109,110]. In addition, during repeated eccentric contractions, the weaker sarcomeres are the first ones that are affected by the above situations, by remaining over-stretched (probably due to the breakdown of titin) and becoming incapable to continue subsequent contractions [74,84,93,95,97,98,99,102,108,109,110]. Hence, the remaining, “stronger” sarcomeres receive even higher loads leading to over-exertion of them, too. This gradually leads to an extensive damage of sarcomeres, breakdown of sarcoplasmic reticulum membranes, and loss of calcium homeostasis in the myocyte [74,84,98,108,109,110]. At this point, the dramatic increase in cytoplasmic calcium causes activation of several calcium-dependent proteolytic and phospholipolytic processes along with disruption of myofibrillar proteins and sarcolemma of the damaged fibers [74,76,78,84,98,111,112,113,114,115,116,117,118]. In addition, eccentric exercise damages mitochondria, sarcoplasmic, and connective tissue network [55,84,87,98,116,117]. The damage appears to worsen within the days following eccentric exercise, reaching a peak at 24–72 h post exercise depending on the type, intensity and loads of exercise and then gradually disappears within 2 or 3 weeks after exercise [14,15,21,55,66,67,71,72,76,79,80,81,82,83,84,85,86,87,88,89,90,93,97,116,117].
The inflammatory response, after EIMD, has been characterized quite well and several excellent original and review articles describe it in detail [15,21,71,74,76,77,78,79,90,93,119]. However, it should be mentioned that the majority of the mechanistic details presented in Figure 1 are based on cellular and animal studies while the inflammatory response in humans is not fully investigated and well addressed. Briefly, it begins immediately after the main mechanical damage when increased Ca2+ concentrations in the cytoplasm lead to degradation of muscle proteins and membrane phospholipids by activation of calpains and phospholipases A2 [114]. Meanwhile, three different types of inflammatory cells enter the injured area after muscle damage, namely, neutrophils and macrophages of type M1 and M2 [the analogs of rats’ CD68 (ED1+) and CD163 (ED2+) in humans].
Their main purpose is to degrade the damaged tissue by releasing active oxygen/nitrogen forms, and induce oxidative stress which is crucial for muscle regeneration after EIMD [14,71,76,87,93,117,120,121,122,123,124]. Neutrophils infiltrate the muscle tissue within a few hours and they phagocytose necrotic muscle fibers and cellular “remnant” while they constitute a source of pro-inflammatory myokines such as IL-1 and TNF-α [71,74,76,78,87,115,123,124,125,126]. Twenty-four hours post-EIMD macrophages appear in the damaged muscle tissue remaining for up to 14 days at the injured sites. The first subpopulation of macrophages are the macrophages expressing the ED1+ antigen and can enter into injured muscle fibers to phagocyte remnant cells and eroded myofibrils. The second subpopulation is ED2+ macrophages whose primary function is the secretion of growth factors and cytokines such as IGF-1, IL-6, and PDGF that can regulate proliferation and differentiation of myoblasts. Although, white blood cells are the main mediators of inflammation, fibroblasts and satellite cells are also “recruited” in the damaged area [71,115,127,128]. Fibroblasts have been shown to produce IL-6 and IL-1α, maintaining by this way the inflammatory response, and activating the proliferation of satellite cells to initiate the regeneration of damaged muscle fibers [71,125,128,129,130,131,132,133,134,135]. In addition, EIMD, elicits reactive oxygen and nitrogen species (RONS) which accompany the inflammatory response. According to the extent of muscle damage, RONS can further damage the muscle tissue but they also play a significant role for muscle regeneration and the adaptation of muscle tissues to eccentric exercise by mediating the up-regulation of antioxidant enzymes and the mitohormetic effects of exercise [14,16,18,70,79,120,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151]. As a consequence of the activation of all the previous mentioned mechanisms in response to EIMD muscle cells’ autophagy, apoptosis, and regeneration-adaptation molecular mechanisms are upregulated, to reinforce the regeneration of muscle cells [103,136,141,144,146,148,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182]. Thus, EIMD is also a successful model to investigate the effect of dietary compounds on the stress-induced mechanisms of autophagy, apoptosis, and regeneration-adaptation molecular cascades. Table 1 summarizes the most common clinical and biochemical indices that are affected by EIMD.

5. Exercise-Induced Muscle Damage and Its Methodological Advantages as an inflammatory Model in Humans

In our opinion, EIMD is a convenient, dynamic, and informative model of inflammation. It can be applied either in studies investigating the homeostatic responses of individuals under inflammatory stimuli or for the estimation of the anti-inflammatory or pro-inflammatory potential of dietary patterns, foods, supplements, nutrients or phytochemicals. The main advantages of EIMD are the following (Figure 2):
  • EIMD can be easily accepted by the volunteers and the bioethics committees. It can be easily induced by different types of exercise/training either in the lower or the upper limbs (see below). The inflammatory response can be applied to all kinds of populations irrespective of their health and training status, age, gender, race, body composition etc. Most importantly, volunteers easily consent to this kind of intervention which is actually just about exercise for them. In addition, most bioethics committees would have no objections to this kind of experimentation in humans.
  • EIMD can be easily applied to humans in a regulated manner. Exercise scientists can induce muscle damage by forcing muscles to lengthen while generating active tension, with various stimuli. As it has been discussed in the previous section, EIMD can be easily induced through eccentric training after 85 to 300 maximal eccentric contractions, while the magnitude and the extent of EIMD from eccentric exercise, seems to be higher and prolonged (lasting for 72 h until 1–2weeks) compared to other type of exercises [14,15,55,62,63,64,66,67,70,72,74,79,84,86,88,90,93,94,97,112,113,117,122,132,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200]. It should be mentioned that eccentric EIMD can be used and recommended for the prevention and/or rehabilitation of many chronic health conditions [94,188,199,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221] since eccentric exercise has about 2–4 times lower metabolic and cardiovascular demands compared to other types of exercises [96,222]. Therefore, it seems that the use of eccentric exercise is a safe, effective, and regulated way to induce EIMD in all population groups. However, other training stimuli could also be applied. For example, high volume drop jump sessions (≥100 jumps) [223,224,225,226,227,228], or in general exercises with an increased volume of stretch-lengthening cycle movements [229], prolonged moderate to high intensity running [196,230,231], cycling [232,233,234,235], and downhill running [236,237,238,239,240], have been repeatedly reported to induce significant EIMD, lasting for more than 72–96 h post-training. Although traditional resistance training (e.g., 60–80% of 1RM, 4–8 sets per exercise) can induce also EIMD [241,242,243] and trigger immune [244,245,246,247,248,249] and inflammation-related molecules (e.g., cytokines and chemokines) responses [245,246,247,248,249,250,251,252], the extent of EIMD is limited or significantly lower and with shorter duration than the above type of exercises, especially compared to eccentric training [74,117,202,253,254]. For most of these exercises, no special instrumentation is required. Independent of the exercise type, EIMD will be stronger and longer if the exercise used is characterized by very high mechanical and metabolic demands, e.g., with high volumes and intensities, fast contraction velocities, high contraction frequencies, short rest periods, and at long muscle lengths [14,15,55,62,63,64,65,66,67,70,71,72,73,74,75,79,84,86,88,90,93,97,112,113,117,122,132,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228]. However, it seems that EIMD is even greater and with longer duration in untrained participants [255] and when a new/different training stimuli (unaccustomed exercise) that voluntaries are not familiar with it is applied [256].
  • The inflammatory mechanisms underlying EIMD are well defined. The muscle microtrauma, induced by the different types of exercise, but mostly from eccentric exercise, can trigger a typical cascade of inflammatory events that resemble aseptic inflammation after tissue damage (see above). It is therefore easier for researchers to identify the crucial mechanistic points that each intervention could affect.
  • One of the biggest advantages of EIMD, is that researchers could have the whole picture of the inflammatory response and its lysis in a strict and regulated time course. In contrast, when individuals with already established low-grade, chronic inflammation are recruited, the variability of the clinical and biochemical phenotypes, pharmacology, and medical history is usually large even in well-controlled studies. Thus, even in the best controlled cross sectional studies, the diversity between the participants would have a strong conflicting impact on research outcomes.
  • Biological sampling. Apart from the classical blood or saliva samples, that are usually collected before and several time points after the exercise trial this type of experiments allow you to take samples of the inflamed tissue, namely muscle biopsies. This technique has been used in many studies, investigating either the training-induced adaptations on muscle fibers (for example [89,122,257,258,259,260,261,262,263]), or muscle damage-inflammation (for example [63,122,128,231,248,264,265,266,267,268,269,270,271]. Muscle samples for such type of studies are usually obtained with Bergstrom needles from vastus lateralis of lower extremities, under local anesthesia, easy and quite safe for the volunteers, while in the majority of the countries, this is well accepted from the bioethics committees. The main advantage of taking muscle samples is that researchers, can investigate inflammation straight on the inflamed tissue and its cells in contrast to the majority of the studies where the inflammatory mechanisms are inferred by the alteration of biochemical markers in the circulation. Muscle biopsies can provide important information on the extent of sarcomere damage, of intra-cell biochemical-molecular procedures and/or genetic background of EIMD.
  • The kinetics of clinical phenotypes linked to the inflammatory response can be easily determined. Such phenotypes are delayed-onset muscle soreness, maximum isometric torque, range of motion, limb circumference, and several other types of ergometric tests according to the inflamed limb.

6. Applications of Exercise Induced Muscle Damage as a Model of Inflammation

The EIMD model can serve as a precise model, in studies investigating the effects of nutritional and training interventions, on acute and chronic inflammation conditions, mainly in metabolic-related inflammatory conditions. As for example, EIMD could serve as a useful model in human studies investigating:
  • Acute and chronic inflammations. EIMD inflammatory response share similar pathophysiological and biochemical responses with acute and chronic inflammation. Thus, EIMD could find application in studies investigating the effect of nutrition and/or exercise, in acute and chronic inflammatory conditions such as those observed before and/or during the majority of chronic and non-communicable diseases [1,2,4,5,8,9,20,24,29,32,33,34,128,272]. For example, the inflammatory status of certain population groups (e.g., obese vs. normal weight) can be better assessed and compared under the dynamic conditions of EIMD. Taking into account that muscle biopsies can also be obtained and then the molecular mechanisms of autophagy, apoptosis and regeneration-adaptation could also be studied [75,103,136,141,144,146,148,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182].
  • Considering the pathophysiology behind conditions such as muscle/neurogenic inflammation, atrophy, cachexia, sarcopenia, and chronic muscle protein degradation EIMD can serve as a very reliable and regulated model to investigate how nutrition and or exercise may affect the physiological and biochemical background of those conditions.
  • Ischemic preconditioning (IPC). After an EIMD stimuli, the following exercise bouts induce lower muscle damage and inflammation, due to the specific muscle adaptations, that minimize the extent of muscle damage, a phenomenon that it is known as “repeated bout effect” (RBE [79,84,273,274,275,276]). IPC protective mechanisms are comparable to those of RBE. IPC attained after one to five cycles of intermittent bouts of Ischemia/reperfusion, provide protection against the possibility of subsequent ischemia with longer duration. It has been documented that ROS are the main cardioprotective factor of IPC. Just a single bout of IPC produces a significant amount of ROS from mitochondria which trigger the protective signaling cascade [139]. Almost the same mechanisms seem to induce the RBE after repeated bouts of training sessions [79,84,273,274,275,276], providing further support that EIMD is a very good model to investigate the IPC and the hormetic effects of diet on those mechanisms.
  • Rhabdomyolysis. Rhabdomyolysis is a pathophysiological condition of extensive skeletal muscle cell damage which could be induced from many physical (trauma, strenuous muscle exercise, electrical current) and non-physical causes (metabolic syndrome, drugs, electrolyte imbalance) [277]. This is a frequent phenomenon in patients taking statins, which may lead to unfavorable effects ranging from myalgia or myopathy to rhabdomyolysis and sometimes to acute renal failure [277]. The initial metabolic hypothesis of statin myopathy is that mitochondrial function is reduced while neutral lipids are increased, and ubiquitin proteasome is activated. In this case the activation of ubiquitin induces acceleration of proteolysis leading to muscle break down, atrophy, and necrosis [278]. Again, drug- and non-drug-induced rhabdomyolysis, have the same mechanisms and responses as those founded during an EIMD situation, specifically of those that are observed during the first 24–48 h post-exercise [14,15,18,21,55,63,65,66,71,72,74,75,76,77,78,79,80,87,90,93,103,116,117,120,121,122,123,136,137,138,140,141,142,143,144,146,148,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,196,197,198,200,279,280,281,282,283,284,285]. Therefore, EIMD can be applied in studies investigating the phenotypes that are more prone to rhabdomyolysis or in studies investigating the protective effects of dietary compounds to it.
  • Fibromyalgia (FM). FM is a complex syndrome characterized by widespread pain that affects many tissues and the presence of allodynia and hyperalgesia [286,287]. Fatigue and functional disorders usually appear during the syndrome [286,287]. Pain is a common feature of EIMD and the physiological-metabolic mechanisms-responses observed in FM are similar to those found during EIMD [288].

7. Conclusions

According to the above, it seems that EIMD is a controlled, highly regulated tool in the hands of researchers, to investigate the ability of different types of nutritional and training interventions to interfere with the progression and lysis of acute inflammatory conditions. It is worth testing if the ability of those interventions to attenuate acute inflammatory responses after EIMD can predict their ability to also act protectively against chronic inflammation although such as link has not been established yet. Nevertheless, EIMD allows the assessment of the putative anti-inflammatory, hermetic, or immunomodulatory properties of dietary intervention directly to human beings under real, dynamic conditions.

Author Contributions

Writing—review and editing, S.M., I.S., S.A., and T.N.; visualization-supervision: T.N. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by the Postgraduate Programme of “Applied Nutrition and Dietetics” of Harokopio University.

Acknowledgments

We would like to thank Cleo Maria Kiourelly for helping with the English Editing.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Donath, M.; Meier, D.; Böni-Schnetzler, M. Inflammation in the pathophysiology and therapy of cardiometabolic disease. Endocr. Rev. 2019, 40, 1080–1091. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Saltiel, A.; Olefsky, J. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 2017, 127, 1–4. [Google Scholar] [CrossRef]
  3. Deng, F.; Shivappa, N.; Tang, Y.; Mann, J.; Hebert, J. Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: Findings from NHANES III. Eur. J. Nutr. 2017, 56, 1085–1093. [Google Scholar] [CrossRef] [PubMed]
  4. Fougère, B.; Boulanger, E.; Nourhashémi, F.; Guyonnet, S.; Cesari, M. Chronic inflammation: Accelerator of biological aging. J. Gerontol. A Biol. Sci. Med. Sci. 2016, 72, 1218–1225. [Google Scholar] [CrossRef] [Green Version]
  5. Draganidis, D.; Karagounis, L.; Athanailidis, I.; Chatzinikolaou, A.; Jamurtas, A.; Fatouros, I. Inflammaging and Skeletal Muscle: Can Protein Intake Make a Difference? J. Nutr. 2016, 146, 1940–1952. [Google Scholar] [CrossRef] [PubMed]
  6. Torres, S.; Fabersani, E.; Marquez, A.; Gauffin-Cano, P. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur. J. Nutr. 2019, 58, 27–43. [Google Scholar] [CrossRef]
  7. Razquin, C.; Martinez-Gonzalez, M. A Traditional Mediterranean Diet Effectively Reduces Inflammation and Improves Cardiovascular Health. Nutrients 2019, 11, 1842. [Google Scholar] [CrossRef] [Green Version]
  8. Koloverou, E.; Panagiotakos, D. Inflammation: A new player in the link between Mediterranean diet and diabetes mellitus: A review. Curr. Nutr. Rep. 2017, 6, 247–256. [Google Scholar] [CrossRef]
  9. Calder, P.; Bosco, N.; Bourdet-Sicard, R.; Capuron, L.; Delzenne, N.; Doré, J.; Franceschi, C.; Lehtinen, M.; Recker, T.; Salvioli, S. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res. Rev. 2017, 40, 95–119. [Google Scholar] [CrossRef]
  10. Calder, P.; Albers, R.; Antoine, J.; Blum, S.; Bourdet-Sicard, R.; Ferns, G.; Folkerts, G.; Friedmann, P.; Frost, G.; Guarner, F. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr. 2009, 101, 1–45. [Google Scholar] [CrossRef] [Green Version]
  11. Lankinen, M.; Uusitupa, M.; Schwab, U. Nordic Diet and Inflammation-A Review of Observational and Intervention Studies. Nutrients 2019, 11, 1396. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Perel, P.; Roberts, I.; Sena, E.; Wheble, P.; Briscoe, C.; Sandercock, P.; Macleod, M.; Mignini, L.; Jayaram, P.; Khan, K. Comparison of treatment effects between animal experiments and clinical trials: Systematic review. BMJ 2007, 334, 197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Laman, J.; Kooistra, S.; Clausen, B. Reproducibility issues: Avoiding pitfalls in animal inflammation models. In Inflammation. Methods in Molecular Biology; Clausen, B., Laman, J., Eds.; Humana Press: New York, NY, USA, 2017; Volume 1559, pp. 1–17. [Google Scholar]
  14. Margaritelis, N.V.; Paschalis, V.; Theodorou, A.A.; Kyparos, A.; Nikolaidis, M.G. Redox basis of exercise physiology. Redox Biol. 2020, 35, 101499. [Google Scholar] [CrossRef]
  15. Peake, J.; Neubauer, O.; Della Gatta, P.; Nosaka, K. Muscle damage and inflammation during recovery from exercise. J. Appl. Physiol. 2017, 122, 559–570. [Google Scholar] [CrossRef]
  16. Parker, L.; Shaw, C.; Stepto, N.; Levinger, I. Exercise and Glycemic Control: Focus on Redox Homeostasis and Redox-Sensitive Protein Signaling. Front. Endocrinol. 2017, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. González, N.; Santivañez, J.; Fuster, B.; Boira, E.; Martinez-Navarro, I.; Bartoll, Ó.; Domingo, C. Quick Recovery of Renal Alterations and Inflammatory Activation after a Marathon. Kidney Dis. 2019, 5, 259–265. [Google Scholar] [CrossRef]
  18. Koyama, K. Exercise-induced oxidative stress: A tool for “hormesis” and “adaptive response”. J. Sports Med. Phys. Fitness. 2014, 3, 115–120. [Google Scholar] [CrossRef]
  19. Hikida, R.; Staron, R.; Hagerman, F.; Sherman, W.; Costill, D. Muscle fiber necrosis associated with human marathon runners. J. Neurol. Sci. 1983, 59, 185–203. [Google Scholar] [CrossRef]
  20. Soehnlein, O.; Steffens, S.; Hidalgo, A.; Weber, C. Neutrophils as protagonists and targets in chronic inflammation. Nat. Rev. Immunol. 2017, 17, 248. [Google Scholar] [CrossRef]
  21. Kajal, H.; Stephen, C.; Elizabeth, D.; Prabha, C.; David, M. Macrophages and the Recovery from Acute and Chronic Inflammation. Annu. Rev. Physiol. 2017, 79, 567–592. [Google Scholar] [CrossRef] [Green Version]
  22. Salminen, A.; Huuskonen, J.; Ojala, J.; Kauppinen, A.; Kaarniranta, K.; Suuronen, T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res. Rev. 2008, 7, 83–105. [Google Scholar] [CrossRef] [PubMed]
  23. Libby, P. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutr. Rev. 2007, 65, S140–S146. [Google Scholar] [CrossRef] [PubMed]
  24. Pietzner, M.; Kaul, A.; Henning, A.; Kastenmüller, G.; Artati, A.; Lerch, M.; Adamski, J.; Nauck, M.; Friedrich, N. Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals. BMC Med. 2017, 15, 210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Soysal, P.; Stubbs, B.; Lucato, P.; Luchini, C.; Solmi, M.; Peluso, R.; Sergi, G.; Isik, A.; Manzato, E.; Maggi, S. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res. Rev. 2016, 31, 1–8. [Google Scholar] [CrossRef] [PubMed]
  26. Lasselin, J.; Capuron, L. Chronic low-grade inflammation in metabolic disorders: Relevance for behavioral symptoms. Neuroimmunomodulation 2014, 21, 95–101. [Google Scholar] [CrossRef] [PubMed]
  27. Chovatiya, R.; Medzhitov, R. Stress, inflammation, and defense of homeostasis. Mol. Cell. 2014, 54, 281–288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Beyer, I.; Mets, T.; Bautmans, I. Chronic low-grade inflammation and age-related sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 12–22. [Google Scholar] [CrossRef]
  29. Monteiro, R.; Azevedo, I. Chronic inflammation in obesity and the metabolic syndrome. Mediat. Inflamm. 2010, 2010, 289645. [Google Scholar] [CrossRef]
  30. Minihane, A.; Vinoy, S.; Russell, W.; Baka, A.; Roche, H.; Tuohy, K.; Teeling, J.; Blaak, E.; Fenech, M.; Vauzour, D.; et al. Low-grade inflammation, diet composition and health: Current research evidence and its translation. Br. J. Nutr. 2015, 114, 999–1012. [Google Scholar] [CrossRef] [Green Version]
  31. Chen, Y.; Liu, S.; Leng, S. Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation. Clin. Ther. 2019, 41, 400–409. [Google Scholar] [CrossRef] [Green Version]
  32. Nishida, K.; Otsu, K. Inflammation and metabolic cardiomyopathy. Cardiovasc. Res. 2017, 113, 389–398. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Hotamisligil, G. Inflammation, metaflammation and immunometabolic disorders. Nature 2017, 542, 177–185. [Google Scholar] [CrossRef] [PubMed]
  34. Kotas, M.; Medzhitov, R. Homeostasis, inflammation, and disease susceptibility. Cell 2015, 160, 816–827. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Durham, W.J.; Dillon, E.L.; Sheffield-Moore, M. Inflammatory burden and amino acid metabolism in cancer cachexia. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12, 72–77. [Google Scholar] [CrossRef] [Green Version]
  36. Danesh, J.; Wheeler, J.; Hirschfield, G.; Eda, S.; Eiriksdottir, G.; Rumley, A.; Lowe, G.; Pepys, M.; Gudnason, V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 2004, 350, 1387–1397. [Google Scholar] [CrossRef]
  37. Mills, P.; Hong, S.; Redwine, L.; Carter, S.; Chiu, A.; Ziegler, M.; Dimsdale, J.; Maisel, A. Physical fitness attenuates leukocyte-endothelial adhesion in response to acute exercise. J. Appl. Physiol. 2006, 101, 785–788. [Google Scholar] [CrossRef]
  38. Petersen, A.M.; Pedersen, B.K. The anti-inflammatory effect of exercise. J. Appl. Physiol. 2005, 98, 1154–1162. [Google Scholar] [CrossRef] [Green Version]
  39. Schwingshackl, L.; Hoffmann, G. Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 929–939. [Google Scholar] [CrossRef]
  40. Ricker, M.; Haas, W. Anti-inflammatory diet in clinical practice: A review. Nutr. Clin. Pract. 2017, 32, 318–325. [Google Scholar] [CrossRef]
  41. Sears, B. Anti-inflammatory diets. J. Am. Coll. Nutr. 2015, 34, 14–21. [Google Scholar] [CrossRef]
  42. Halliwell, B. Antioxidant and Anti-Inflammatory Components of Foods; ILSI Europe: Brussels, Belgium, 2015; p. 34. [Google Scholar]
  43. Galland, L. Diet and inflammation. Nutr. Clin. Pract. 2010, 25, 634–640. [Google Scholar] [CrossRef]
  44. Arouca, A.; Meirhaeghe, A.; Dallongeville, J.; Moreno, L.; Lourenço, G.; Marcos, A.; Huybrechts, I.; Manios, Y.; Lambrinou, C.; Gottrand, F. Interplay between the Mediterranean diet and C-reactive protein genetic polymorphisms towards inflammation in adolescents. Clin. Nutr. 2020, 39, 1919–1926. [Google Scholar] [CrossRef] [PubMed]
  45. Nomikos, T.; Fragopoulou, E.; Antonopoulou, S.; Panagiotakos, D. Mediterranean diet and platelet-activating factor; a systematic review. Clin. Biochem. 2018, 60, 1–10. [Google Scholar] [CrossRef]
  46. Seok, J.; Warren, S.; Cuenca, A.; Mindrinos, M.; Baker, H.; Xu, W.; Richards, D.; McDonald-Smith, G.; Gao, H.; Hennessy, L. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2013, 110, 3507–3512. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Gambini, J.; Inglés, M.; Olaso, G.; Lopez-Grueso, R.; Bonet-Costa, V.; Gimeno-Mallench, L.; Mas-Bargues, C.; Abdelaziz, K.; Gomez-Cabrera, M.; Vina, J. Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxidative Med. Cell. Longev. 2015, 2015. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Webb, D. Animal models of human disease: Inflammation. Biochem. Pharmacol. 2014, 87, 121–130. [Google Scholar] [CrossRef] [PubMed]
  49. Ahluwalia, N.; Andreeva, V.; Kesse-Guyot, E.; Hercberg, S. Dietary patterns, inflammation and the metabolic syndrome. Diabetes Metab. 2013, 39, 99–110. [Google Scholar] [CrossRef]
  50. Wang, X.; Ouyang, Y.; Liu, J.; Zhao, G. Flavonoid intake and risk of CVD: A systematic review and meta-analysis of prospective cohort studies. Br. J. Nutr. 2014, 111, 1–11. [Google Scholar] [CrossRef] [Green Version]
  51. Rangel-Huerta, O.; Aguilera, C.; Mesa, M.; Gil, A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: A systematic review of randomised clinical trials. Br. J. Nutr. 2012, 107, S159–S170. [Google Scholar] [CrossRef] [Green Version]
  52. Schwingshackl, L.; Christoph, M.; Hoffmann, G. Effects of olive oil on markers of inflammation and endothelial function—a systematic review and meta-analysis. Nutrients 2015, 7, 7651–7675. [Google Scholar] [CrossRef] [Green Version]
  53. Buyken, A.; Goletzke, J.; Joslowski, G.; Felbick, A.; Cheng, G.; Herder, C.; Brand-Miller, J. Association between carbohydrate quality and inflammatory markers: Systematic review of observational and interventional studies. Am. J. Clin. Nutr. 2014, 99, 813–833. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Moradi, S.; Issah, A.; Mohammadi, H.; Mirzaei, K. Associations between dietary inflammatory index and incidence of breast and prostate cancer: A systematic review and meta-analysis. Nutrition 2018, 55, 168–178. [Google Scholar] [CrossRef] [PubMed]
  55. Owens, D.; Twist, C.; Cobley, J.; Howatson, G.; Close, G. Exercise-induced muscle damage: What is it, what causes it and what are the nutritional solutions? Eur. J. Sport Sci. 2018, 19, 71–85. [Google Scholar] [CrossRef] [PubMed]
  56. Fouré, A.; Bendahan, D. Is branched-chain amino acids supplementation an efficient nutritional strategy to alleviate skeletal muscle damage? A systematic review. Nutrients 2017, 9, 1047. [Google Scholar] [CrossRef] [Green Version]
  57. Pasiakos, S.; Lieberman, H.; McLellan, T. Effects of protein supplements on muscle damage, soreness and recovery of muscle function and physical performance: A systematic review. Sports Med. 2014, 44, 655–670. [Google Scholar] [CrossRef]
  58. Cockburn, E.; Bell, P.; Stevenson, E. Effect of milk on team sport performance after exercise-induced muscle damage. Med. Sci. Sports Exerc. 2013, 45, 1585–1592. [Google Scholar] [CrossRef]
  59. Cockburn, E.; Hayes, P.; French, D.; Stevenson, E.; St Clair Gibson, A. Acute milk-based protein–CHO supplementation attenuates exercise-induced muscle damage. Appl. Physiol. Nutr. Metab. 2008, 33, 775–783. [Google Scholar] [CrossRef]
  60. Harty, P.; Cottet, M.; Malloy, J.; Kerksick, C. Nutritional and Supplementation Strategies to Prevent and Attenuate Exercise-Induced Muscle Damage: A Brief Review. Sports Med. Open 2019, 5, 1. [Google Scholar] [CrossRef]
  61. Sousa, M.; Teixeira, V.; Soares, J. Dietary strategies to recover from exercise-induced muscle damage. Int. J. Food Sci. Nutr. 2014, 65, 151–163. [Google Scholar] [CrossRef]
  62. Margaritelis, N.; Paschalis, V.; Theodorou, A.; Kyparos, A.; Nikolaidis, M. Antioxidants in Personalized Nutrition and Exercise. Adv. Nutr. 2018, 9, 813–823. [Google Scholar] [CrossRef] [Green Version]
  63. Michailidis, Y.; Karagounis, L.; Terzis, G.; Jamurtas, A.; Spengos, K.; Tsoukas, D.; Chatzinikolaou, A.; Mandalidis, D.; Stefanetti, R.; Papassotiriou, I. Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am. J. Clin. Nutr. 2013, 98, 233–245. [Google Scholar] [CrossRef] [Green Version]
  64. Paschalis, V.; Theodorou, A.; Margaritelis, N.; Kyparos, A.; Nikolaidis, M. N-acetylcysteine supplementation increases exercise performance and reduces oxidative stress only in individuals with low levels of glutathione. Free Radic. Biol. Med. 2017, 115, 288–297. [Google Scholar] [CrossRef] [PubMed]
  65. Margaritelis, N.; Theodorou, A.; Paschalis, V.; Veskoukis, A.; Dipla, K.; Zafeiridis, A.; Panayiotou, G.; Vrabas, I.S.; Kyparos, A.; Nikolaidis, M. Adaptations to endurance training depend on exercise-induced oxidative stress: Exploiting redox inter-individual variability. Acta Physiol. 2017, 222, e12972. [Google Scholar] [CrossRef] [PubMed]
  66. Kotsis, Y.; Mikellidi, A.; Aresti, C.; Persia, E.; Sotiropoulos, A.; Panagiotakos, D.; Antonopoulou, S.; Nomikos, T. A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players. Eur. J. Nutr. 2018, 57, 1181–1195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Kotsis, Y.; Methenitis, S.; Mikellidi, A.; Aresti, C.; Persia, E.; Antonopoulou, S.; Nomikos, T. Changes of rate of torque development in soccer players after a Loughborough Intermittent Shuttle Test: Effect of bovine colostrum supplementation. Isokinet. Exerc. Sci. 2020, 28, 59–72. [Google Scholar] [CrossRef]
  68. Bongiovanni, T.; Genovesi, F.; Nemmer, M.; Carling, C.; Alberti, G.; Howatson, G. Nutritional interventions for reducing the signs and symptoms of exercise-induced muscle damage and accelerate recovery in athletes: Current knowledge, practical application and future perspectives. Eur. J. Appl. Physiol. 2020, 120, 1965–1996. [Google Scholar] [CrossRef]
  69. Panza, V.P.; Diefenthaeler, F.; Da Silva, E. Benefits of dietary phytochemical supplementation on eccentric exercise-induced muscle damage: Is including antioxidants enough? Nutrition 2015, 31, 1072–1082. [Google Scholar] [CrossRef]
  70. Margaritelis, N.; Paschalis, V.; Theodorou, A.; Kyparos, A.; Nikolaidis, M. Antioxidant supplementation, redox deficiencies and exercise performance: A falsification design. Free Radic. Biol. Med. 2020, 158, 44–52. [Google Scholar] [CrossRef]
  71. Paulsen, G.; Mikkelsen, U.R.; Raastad, T.; Peake, J. Leucocytes, cytokines and satellite cells: What role do they play in muscle damage and regeneration following eccentric exercise? Exerc. Immunol. Rev. 2012, 18, 42–97. [Google Scholar]
  72. Jamurtas, A.; Fatouros, I. Eccentric Exercise, Muscle Damage and Oxidative Stress. In An International Perspective on Topics in Sports Med. and Sports Injury; Zaslav, K., Ed.; IntechOpen: London, UK, 2012; pp. 113–130. [Google Scholar] [CrossRef] [Green Version]
  73. Clarkson, P.M.; Hubal, M.J. Exercise-induced muscle damage in humans. Am. J. Phys. Med. Rehabil. 2002, 81, S52–S69. [Google Scholar] [CrossRef]
  74. Proske, U.; Morgan, D. Muscle damage from eccentric exercise: Mechanism, mechanical signs, adaptation and clinical applications. J. Physiol. 2001, 537, 333–345. [Google Scholar] [CrossRef] [PubMed]
  75. Methenitis, S. A Brief Review on Concurrent Training: From Laboratory to the Field. Sports 2018, 6, 127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Chazaud, B. Inflammation during skeletal muscle regeneration and tissue remodeling: Application to exercise-induced muscle damage management. Immunol. Cell Biol. 2016, 94, 140–145. [Google Scholar] [CrossRef] [PubMed]
  77. Malm, C. Exercise-induced muscle damage and inflammation: Fact or fiction? Acta Physiol. Scand. 2001, 171, 233–239. [Google Scholar] [CrossRef] [PubMed]
  78. Tidball, J.; Villalta, A. Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298, R1173–R1187. [Google Scholar] [CrossRef] [Green Version]
  79. Margaritelis, N.; Theodorou, A.; Baltzopoulos, V.; Maganaris, C.; Paschalis, V.; Kyparos, A.; Nikolaidis, M. Muscle damage and inflammation after eccentric exercise: Can the repeated bout effect be removed? Physiol. Rep. 2015, 3, e12648. [Google Scholar] [CrossRef] [Green Version]
  80. Tokinoya, K.; Ishikura, K.; Ra, S.; Ebina, K.; Miyakawa, S.; Ohmori, H. Relationship between early-onset muscle soreness and indirect muscle damage markers and their dynamics after a full marathon. J. Exerc. Sci. Fit. 2020, 18, 115–121. [Google Scholar] [CrossRef]
  81. Carmona, G.; Roca, E.; Guerrero, M.; Cussó, R.; Bàrcena, C.; Mateu, M.; Cadefau, J. Fibre-type-specific and Mitochondrial Biomarkers of Muscle Damage after Mountain Races. Int. J. Sports Med. 2019, 40, 253–262. [Google Scholar] [CrossRef] [Green Version]
  82. Flann, K.L.; LaStayo, P.C.; McClain, D.A.; Hazel, M.; Lindstedt, S.L. Muscle damage and muscle remodeling: No pain, no gain? J. Exp. Biol. 2011, 214, 674–679. [Google Scholar] [CrossRef] [Green Version]
  83. Baumert, P.; Lake, M.J.; Stewart, C.E.; Drust, B.; Erskine, R.M. Genetic variation and exercise-induced muscle damage: Implications for athletic performance, injury and ageing. Eur. J. Appl. Physiol. 2016, 116, 1595–1625. [Google Scholar] [CrossRef] [Green Version]
  84. Hyldahl, R.; Hubal, M. Lengthening our perspective: Morphological, cellular, and molecular responses to eccentric exercise. Muscle Nerve. 2014, 49, 155–170. [Google Scholar] [CrossRef]
  85. Cheung, K.; Hume, P.; Maxwell, L. Delayed onset muscle soreness. Sports Med. 2003, 33, 145–164. [Google Scholar] [CrossRef] [PubMed]
  86. Paschalis, V.; Koutedakis, Y.; Jamurtas, A.; Mougios, V.; Baltzopoulos, V. Equal volumes of high and low intensity of eccentric exercise in relation to muscle damage and performance. J. Strength Cond. Res. 2005, 19, 184–188. [Google Scholar] [CrossRef] [PubMed]
  87. Kerksick, C.M.; Willoughby, D.; Kouretas, D.; Tsatsakis, A. Intramuscular responses with muscle damaging exercise and the interplay between multiple intracellular networks: A human perspective. Food Chem. Toxicol. 2013, 61, 136–143. [Google Scholar] [CrossRef] [PubMed]
  88. Peake, J.; Nosaka, K.; Suzuki, K. Characterization of inflammatory responses to eccentric exercise in humans. Exerc. Immunol. Rev. 2005, 11, 64–85. [Google Scholar] [PubMed]
  89. Methenitis, S.; Mpampoulis, T.; Spiliopoulou, P.; Papadimas, G.; Papadopoulos, C.; Chalari, E.; Evangelidou, E.; Stasinaki, A.N.; Nomikos, T.; Terzis, G. Muscle fiber composition, jumping performance and rate of force development adaptations induced by different power training volumes in females. Appl. Physiol. Nutr. Metab. 2020, 45, 996–1006. [Google Scholar] [CrossRef] [PubMed]
  90. Hody, S.; Croisier, J.; Bury, T.; Rogister, B.; Leprince, P. Eccentric muscle contractions: Risks and benefits. Front. Physiol. 2019, 10. [Google Scholar] [CrossRef]
  91. Bogdanis, G.; Tsoukos, A.; Brown, L.; Selima, E.; Veligekas, P.; Spengos, K.; Terzis, G. Muscle fiber and performance changes after fast eccentric complex training. Med. Sci. Sports Exerc. 2018, 50, 729–738. [Google Scholar] [CrossRef]
  92. Tinwala, F.; Cronin, J.; Haemmerle, E.; Ross, A. Eccentric Strength Training: A Review of the Available Technology. Strength Cond. J. 2017, 39, 32–47. [Google Scholar] [CrossRef]
  93. Douglas, J.; Pearson, S.; Ross, A.; McGuigan, M. Eccentric exercise: Physiological characteristics and acute responses. Sports Med. 2017, 47, 663–675. [Google Scholar] [CrossRef]
  94. Douglas, J.; Pearson, S.; Ross, A.; McGuigan, M. Chronic Adaptations to Eccentric Training: A Systematic Review. Sports Med. 2016, 47, 917–941. [Google Scholar] [CrossRef] [PubMed]
  95. Vogt, M.; Hoppeler, H. Eccentric exercise: Mechanisms and effects when used as training regime or training adjunct. J. Appl. Physiol. 2014, 116, 1446–1454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Isner-Horobeti, M.E.; Dufour, S.P.; Vautravers, P.; Geny, B.; Coudeyre, E.; Richard, R. Eccentric exercise training: Modalities, applications and perspectives. Sports Med. 2013, 43, 483–512. [Google Scholar] [CrossRef] [PubMed]
  97. Proske, U.; Allen, T. Damage to skeletal muscle from eccentric exercise. Exerc. Sport Sci. Rev. 2005, 33, 98–104. [Google Scholar] [CrossRef]
  98. Nishikawa, K. Eccentric contraction: Unraveling mechanisms of force enhancement and energy conservation. J. Exp. Biol. 2016, 219, 189–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Lieber, R. Biomechanical response of skeletal muscle to eccentric contractions. J. Sport Health Sci. 2018, 7, 294–309. [Google Scholar] [CrossRef]
  100. Gordon, A.; Huxley, A.; Julian, F. The variation in isometric tension with sarcomere length in vertebrate muscle fibres. J. Physiol. 1966, 184, 170–192. [Google Scholar] [CrossRef]
  101. Maganaris, C. Force–length characteristics of in vivo human skeletal muscle. Acta Physiol. Scand. 2001, 172, 279–285. [Google Scholar] [CrossRef] [Green Version]
  102. Leonard, T.; Herzog, W. Regulation of muscle force in the absence of actin-myosin-based cross-bridge interaction. Am. J. Physiol. Cell Physiol. 2010, 299, C14–C20. [Google Scholar] [CrossRef] [Green Version]
  103. Krüger, M.; Kötter, S. Titin, a Central Mediator for Hypertrophic Signaling, Exercise-Induced Mechanosignaling and Skeletal Muscle Remodeling. Front. Physiol. 2016, 7. [Google Scholar] [CrossRef] [Green Version]
  104. Bottinelli, R.; Canepari, M.; Pellegrino, M.A.; Reggiani, C. Force-velocity properties of human skeletal muscle fibres: Myosin heavy chain isoform and temperature dependence. J. Physiol. 1996, 495 Pt 2, 573–586. [Google Scholar] [CrossRef]
  105. Babault, N.; Pousson, M.; Ballay, Y.; Van Hoecke, J. Activation of human quadriceps femoris during isometric, concentric, and eccentric contractions. J. Appl. Physiol. 2001, 91, 2628–2634. [Google Scholar] [CrossRef] [PubMed]
  106. Enoka, R.M. Eccentric contractions require unique activation strategies by the nervous system. J. Appl. Physiol. 1996, 81, 2339–2346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Aagaard, P. Spinal and supraspinal control of motor function during maximaleccentric muscle contraction: Effects of resistance training. J. Sport Health Sci. 2018, 7, 282–293. [Google Scholar] [CrossRef]
  108. Morgan, D.; Allen, D. Early events in stretch-induced muscle damage. J. Appl. Physiol. 1999, 87, 2007–2015. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  109. Lieber, R.; Friden, J. Muscle damage is not a function of muscle force but active muscle strain. J. Appl. Physiol. 1993, 74, 520–526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Friden, J.; Lieber, R. Structural and mechanical basis of exercise-induced muscle injury. Med. Sci. Sports Exerc. 1992, 24, 521–530. [Google Scholar] [CrossRef]
  111. Lee, K.; Ochi, E.; Song, H.; Nakazato, K. Activation of AMP-activated protein kinase induce expression of FoxO1, FoxO3a, and myostatin after exercise-induced muscle damage. Biochem. Biophys. Res. Commun. 2015, 466, 289–294. [Google Scholar] [CrossRef]
  112. Jiménez-Jiménez, R.; Cuevas, M.; Almar, M.; Lima, E.; García-López, D.; De Paz, J.; González-Gallego, J. Eccentric training impairs NF-κB activation and over-expression of inflammation-related genes induced by acute eccentric exercise in the elderly. Mech. Ageing Dev. 2008, 129, 313–321. [Google Scholar] [CrossRef]
  113. Murphy, R.; Goodman, C.; McKenna, M.; Bennie, J.; Leikis, M.; Lamb, G. Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J. Appl. Physiol. 2007, 103, 926–931. [Google Scholar] [CrossRef] [Green Version]
  114. Belcastro, A.; Shewchuk, L.; Raj, D. Exercise-induced muscle injury: A calpain hypothesis. Mol. Cell. Biochem. 1998, 179, 135–145. [Google Scholar] [CrossRef] [PubMed]
  115. Charge, S.; Rudnicki, M. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 2004, 84, 209–238. [Google Scholar] [CrossRef] [PubMed]
  116. Kim, J.; Lee, J.; Kim, S.; Ryu, H.Y.; Cha, K.; Sung, D.J. Exercise-induced rhabdomyolysis mechanisms and prevention: A literature review. J. Sport Health Sci. 2016, 5, 324–333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Franchi, M.; Reeves, N.; Narici, M. Skeletal Muscle Remodeling in Response to Eccentric vs. Concentric Loading: Morphological, Molecular, and Metabolic Adaptations. Front. Physiol. 2017, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. Ulbricht, A.; Gehlert, S.; Leciejewski, B.; Schiffer, T.; Bloch, W.; Höhfeld, J. Induction and adaptation of chaperone-assisted selective autophagy CASA in response to resistance exercise in human skeletal muscle. Autophagy 2015, 11, 538–546. [Google Scholar] [CrossRef] [Green Version]
  119. Philippou, A.; Bogdanis, G.; Maridaki, M.; Halapas, A.; Sourla, A.; Koutsilieris, M. Systemic cytokine response following exercise-induced muscle damage in humans. Clin. Chem. Lab. Med. 2009, 47, 777–782. [Google Scholar] [CrossRef] [Green Version]
  120. Cheng, A.; Yamada, T.; Rassier, D.; Andersson, D.; Westerblad, H.; Lanner, J. Reactive oxygen/nitrogen species and contractile function in skeletal muscle during fatigue and recovery. J. Physiol. 2016, 594, 5149–5160. [Google Scholar] [CrossRef] [Green Version]
  121. Zuo, L.; Pannell, B. Redox Characterization of Functioning Skeletal Muscle. Front. Physiol. 2015, 6. [Google Scholar] [CrossRef] [Green Version]
  122. Wright, C.R.; Brown, E.L.; Della Gatta, P.A.; Fatouros, I.G.; Karagounis, L.G.; Terzis, G.; Mastorakos, G.; Michailidis, Y.; Mandalidis, D.; Spengos, K.; et al. Regulation of Granulocyte Colony-Stimulating Factor and Its Receptor in Skeletal Muscle Is Dependent Upon the Type of Inflammatory Stimulus. J. Interferon Cytokine Res. 2015, 35, 710–719. [Google Scholar] [CrossRef]
  123. Tidball, J. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R345–R353. [Google Scholar] [CrossRef] [Green Version]
  124. Brunelli, S.; Rovere-Querini, P. The immune system and the repair of skeletal muscle. Pharmacol. Res. 2008, 58, 117–121. [Google Scholar] [CrossRef] [PubMed]
  125. Toth, K.; McKay, B.; De Lisio, M.; Little, J.; Tarnopolsky, M.; Parise, G. IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS ONE 2011, 6, e17392. [Google Scholar] [CrossRef] [PubMed]
  126. Costamagna, D.; Costelli, P.; Sampaolesi, M.; Penna, F. Role of Inflammation in Muscle Homeostasis and Myogenesis. Mediat. Inflamm. 2015, 501, 805172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  127. Pedersen, K.; Steensberg, A.; Keller, P.; Keller, C.; Fischer, C.; Hiscock, N.; Van Hall, G.; Plomgaard, P.; Febbraio, M. Muscle-derived interleukin-6: Lipolytic, anti-inflammatory and immune regulatory effects. Pflug. Arch. 2003, 446, 9–16. [Google Scholar] [CrossRef]
  128. Perandini, L.; Chimin, P.; Lutkemeyer, D.S.; Câmara, N. Chronic inflammation in skeletal muscle impairs satellite cells function during regeneration: Can physical exercise restore the satellite cell niche? FEBS J. 2018, 285, 1973–1984. [Google Scholar] [CrossRef] [Green Version]
  129. Hawke, T.; Garry, D. Myogenic satellite cells: Physiology to molecular biology. J. Appl. Physiol. 2001, 91, 534–551. [Google Scholar] [CrossRef] [PubMed]
  130. Serrano, A.; Baeza-Raja, B.; Perdiguero, E.; Jardí, M.; Muñoz-Cánoves, P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008, 7, 33–44. [Google Scholar] [CrossRef] [Green Version]
  131. Muñoz-Cánoves, P.; Scheele, C.; Pedersen, B.; Serrano, A. Interleukin-6 myokine signaling in skeletal muscle: A double-edged sword? FEBS J. 2013, 280, 4131–4148. [Google Scholar] [CrossRef] [PubMed]
  132. Cermak, N.; Snijders, T.; McKay, B.; Parise, G.; Verdijk, L.; Tarnopolsky, M.; Gibala, M.; Van Loon, L.J. Eccentric exercise increases satellite cell content in type II muscle fibers. Med. Sci. Sports Exerc. 2013, 45, 230–237. [Google Scholar] [CrossRef]
  133. Dumont, N.; Bentzinger, F.; Sincennes, M.C.; Rudnicki, M. Satellite cells and skeletal muscle regeneration. Compr. Physiol. 2015. [Google Scholar] [CrossRef]
  134. Furuichi, Y.; Fujii, N. Mechanism of satellite cell regulation by myokines. J. Sports Med. Phys. Fitness. 2017, 6, 311–316. [Google Scholar] [CrossRef]
  135. Snijders, T.; Verdijk, L.; Beelen, M.; McKay, B.; Parise, G.; Kadi, F.; Van Loon, L. A single bout of exercise activates skeletal muscle satellite cells during subsequent overnight recovery. Exp. Physiol. 2012, 97, 762–773. [Google Scholar] [CrossRef] [PubMed]
  136. Morales-Alamo, D.; Calbet, J.A. AMPK signaling in skeletal muscle during exercise: Role of reactive oxygen and nitrogen species. Free Radic. Biol. Med. 2016, 98, 68–77. [Google Scholar] [CrossRef] [PubMed]
  137. Thirupathi, A.; Pinho, R. Effects of reactive oxygen species and interplay of antioxidants during physical exercise in skeletal muscles. J. Physiol. Biochem. 2018, 74, 359–367. [Google Scholar] [CrossRef] [PubMed]
  138. Aguiló, A.; Tauler, P.; Fuentespina, E.; Tur, J.; Córdova, A.; Pons, A. Antioxidant response to oxidative stress induced by exhaustive exercise. Physiol. Behav. 2005, 84, 1–7. [Google Scholar] [CrossRef] [PubMed]
  139. Alleman, R.; Katunga, L.; Nelson, M.; Brown, D.; Anderson, E. The “Goldilocks Zone” from a redox perspective—Adaptive vs. deleterious responses to oxidative stress in striated muscle. Front. Physiol. 2014, 5. [Google Scholar] [CrossRef] [Green Version]
  140. Cooper, C.; Vollaard, N.B.; Choueiri, T.; Wilson, M. Exercise, free radicals and oxidative stress. Biochem. Soc. Trans. 2002, 30, 280–284. [Google Scholar] [CrossRef]
  141. Filomeni, G.; De Zio, D.; Cecconi, F. Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death Differ. 2015, 22, 377–388. [Google Scholar] [CrossRef] [Green Version]
  142. Pittaluga, M.; Parisi, P.; Sabatini, S.; Ceci, R.; Caporossi, D.; Catani, M.V.; Savini, I.; Avigliano, L. Cellular and biochemical parameters of exercise-induced oxidative stress: Relationship with training levels. Free Radic. Res. 2006, 40, 607–614. [Google Scholar] [CrossRef]
  143. Steinbacher, P.; Eckl, P. Impact of oxidative stress on exercising skeletal muscle. Biomolecules 2015, 5, 356–377. [Google Scholar] [CrossRef]
  144. Ferraro, E.; Giammarioli, A.; Chiandotto, S.; Spoletini, I.; Rosano, G. Exercise-induced skeletal muscle remodeling and metabolic adaptation: Redox signaling and role of autophagy. Antioxid. Redox Signal. 2014, 21, 154–176. [Google Scholar] [CrossRef] [PubMed]
  145. Fyfe, J.J.; Bishop, D.; Stepto, N. Interference between Concurrent Resistance and Endurance Exercise: Molecular Bases and the Role of Individual Training Variables. Sports Med. 2014, 44, 743–762. [Google Scholar] [CrossRef] [PubMed]
  146. Fyfe, J.J.; Bishop, D.; Zacharewicz, E.; Russell, A.; Stepto, N. Concurrent exercise incorporating high-intensity interval or continuous training modulates mTORC1 signaling and microRNA expression in human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016, 310, R1297–R1311. [Google Scholar] [CrossRef] [PubMed]
  147. Olesen, J.; Kiilerich, K.; Pilegaard, H. PGC-1α-mediated adaptations in skeletal muscle. Pflug. Arch. 2010, 460, 153–162. [Google Scholar] [CrossRef] [PubMed]
  148. Joshua, D.; Rebecca, W.; Zhen, Y. Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle. FASEB J. 2016, 30, 13–22. [Google Scholar] [CrossRef]
  149. Lundby, C.; Jacobs, R. Adaptations of skeletal muscle mitochondria to exercise training. Exp. Physiol. 2016, 101, 17–22. [Google Scholar] [CrossRef]
  150. Seene, T.; Kaasik, P.; Seppet, E. Changes in Myofibrillar and Mitochondrial Compartments during Increased Activity: Dependance from Oxidative Capacity of Muscle. Health 2017, 9, 779. [Google Scholar] [CrossRef] [Green Version]
  151. Yan, Z.; Okutsu, M.; Akhtar, Y.; Lira, V. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J. Appl. Physiol. 2011, 110, 264–274. [Google Scholar] [CrossRef] [Green Version]
  152. Rodney, G.; Pal, R.; Abo-Zahrah, R. Redox regulation of autophagy in skeletal muscle. Free Radic. Biol. Med. 2016, 98, 103–112. [Google Scholar] [CrossRef] [Green Version]
  153. Vainshtein, A.; Grumati, P.; Sandri, M.; Bonaldo, P. Skeletal muscle, autophagy, and physical activity: The ménage à trois of metabolic regulation in health and disease. J. Mol. Med. 2014, 92, 127–137. [Google Scholar] [CrossRef]
  154. Tam, B.; Siu, P. Autophagic Cellular Responses to Physical Exercise in Skeletal Muscle. Sports Med. 2014, 44, 625–640. [Google Scholar] [CrossRef] [PubMed]
  155. Martin-Rincon, M.; Morales-Alamo, D.; Calbet, J. Exercise-mediated modulation of autophagy in skeletal muscle. Scand. J. Med. Sci. Sports 2018, 28, 772–781. [Google Scholar] [CrossRef]
  156. Fritzen, A.; Madsen, A.; Kleinert, M.; Treebak, J.; Lundsgaard, A.; Jensen, T.; Richter, E.; Wojtaszewski, J.; Kiens, B.; Frøsig, C. Regulation of autophagy in human skeletal muscle: Effects of exercise, exercise training and insulin stimulation. J. Physiol. 2016, 594, 745–761. [Google Scholar] [CrossRef] [PubMed]
  157. Gao, H.; Li, Y. Distinct signal transductions in fast- and slow- twitch muscles upon denervation. Physiol. Rep. 2018, 6, e13606. [Google Scholar] [CrossRef]
  158. Schwalm, C.; Jamart, C.; Benoit, N.; Naslain, D.; Prémont, C.; Prévet, J.; Van Thienen, R.; Deldicque, L.; Francaux, M. Activation of autophagy in human skeletal muscle is dependent on exercise intensity and AMPK activation. FASEB J. 2015, 29, 3515–3526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  159. Rocchi, A.; He, C. Regulation of Exercise-Induced Autophagy in Skeletal Muscle. Curr. Pathobiol. Rep. 2017, 5, 177–186. [Google Scholar] [CrossRef]
  160. Halling, J.; Pilegaard, H. Autophagy-Dependent Beneficial Effects of Exercise. Cold Spring Harb. Perspect. Med. 2017, 7. [Google Scholar] [CrossRef] [Green Version]
  161. Vainshtein, A.; Hood, D. The regulation of autophagy during exercise in skeletal muscle. J. Appl. Physiol. 2016, 120, 664–673. [Google Scholar] [CrossRef] [Green Version]
  162. Codina-Martínez, H.; Fernández-García, B.; Díez-Planelles, C.; Fernández, Á.; Higarza, S.; Fernández-Sanjurjo, M.; Díez-Robles, S.; Iglesias-Gutiérrez, E.; Tomás-Zapico, C. Autophagy is required for performance adaptive response to resistance training and exercise-induced adult neurogenesis. Scand. J. Med. Sci. Sports 2020, 30, 238–253. [Google Scholar] [CrossRef]
  163. Martin-Rincon, M.; Pérez-López, A.; Morales-Alamo, D.; Perez-Suarez, I.; De Pablos-Velasco, P.; Perez-Valera, M.; Perez-Regalado, S.; Martinez-Canton, M.; Gelabert-Rebato, M.; Juan-Habib, J. Exercise Mitigates the Loss of Muscle Mass by Attenuating the Activation of Autophagy during Severe Energy Deficit. Nutrients 2019, 11, 2824. [Google Scholar] [CrossRef] [Green Version]
  164. Brandt, N.; Gunnarsson, T.; Bangsbo, J.; Pilegaard, H. Exercise and exercise training-induced increase in autophagy markers in human skeletal muscle. Physiol. Rep. 2018, 6, e13651. [Google Scholar] [CrossRef] [PubMed]
  165. Moberg, M.; Hendo, G.; Jakobsson, M.; Mattsson, M.; Ekblom-Bak, E.; Flockhart, M.; Pontén, M.; Söderlund, K.; Ekblom, B. Increased autophagy signaling but not proteasome activity in human skeletal muscle after prolonged low-intensity exercise with negative energy balance. Physiol. Rep. 2017, 5, e13518. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  166. Hentilä, J.; Ahtiainen, J.P.; Paulsen, G.; Raastad, T.; Häkkinen, K.; Mero, A.A.; Hulmi, J.J. Autophagy is induced by resistance exercise in young men, but unfolded protein response is induced regardless of age. Acta Physiol. 2018, 224, e13069. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  167. Ahtiainen, J. Physiological and Molecular Adaptations to Strength Training. In Concurrent Aerobic and Strength Training: Scientific Basics and Practical Applications; Schumann, M., Rønnestad, B.R., Eds.; Springer International Publishing: Cham, Switzerland, 2019; pp. 51–73. [Google Scholar] [CrossRef]
  168. Anthony, S.; Henri, B.; Guillaume, P.; Robin, C. Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 307, R956–R969. [Google Scholar] [CrossRef]
  169. Saxton, R.; Sabatini, D. mTOR signaling in growth, metabolism, and disease. Cell 2017, 168, 960–976. [Google Scholar] [CrossRef] [Green Version]
  170. Haun, C.; Mumford, P.; Roberson, P.; Romero, M.; Mobley, C.; Kephart, W.; Anderson, R.; Colquhoun, R.; Muddle, T.; Luera, M. Molecular, neuromuscular, and recovery responses to light versus heavy resistance exercise in young men. Physiol. Rep. 2017, 5, e13457. [Google Scholar] [CrossRef]
  171. Smiles, W.; Areta, J.; Coffey, V.; Phillips, S.; Moore, D.; Stellingwerff, T.; Burke, L.; Hawley, J.; Camera, D. Modulation of autophagy signaling with resistance exercise and protein ingestion following short-term energy deficit. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2015, 309, R603–R612. [Google Scholar] [CrossRef] [Green Version]
  172. Sakuma, K.; Yamaguchi, A. Molecular Mechanisms Controlling Skeletal Muscle Mass. In Muscle Cell and Tissue; IntechOpen: London, UK, 2015. [Google Scholar]
  173. Schiaffino, S.; Dyar, K.; Ciciliot, S.; Blaauw, B.; Sandri, M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013, 280, 4294–4314. [Google Scholar] [CrossRef]
  174. Fernandez-Gonzalo, R.; Lundberg, T.R.; Tesch, P.A. Acute molecular responses in untrained and trained muscle subjected to aerobic and resistance exercise training versus resistance training alone. Acta Physiol. 2013, 209, 283–294. [Google Scholar] [CrossRef]
  175. De Souza, E.O.; Tricoli, V.; Roschel, H.; Brum, P.C.; Bacurau, A.V.; Ferreira, J.C.; Aoki, M.S.; Neves-Jr, M.; Aihara, A.Y.; Da Rocha Correa Fernandes, A. Molecular adaptations to concurrent training. Int. J. Sports Med. 2013, 34, 207–213. [Google Scholar] [CrossRef] [Green Version]
  176. Powell, J.; Pollizzi, K.; Heikamp, E.; Horton, M. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 2012, 30, 39–68. [Google Scholar] [CrossRef] [Green Version]
  177. Hulmi, J.; Walker, S.; Ahtiainen, J.P.; Nyman, K.; Kraemer, W.J.; Häkkinen, K. Molecular signaling in muscle is affected by the specificity of resistance exercise protocol. Scand. J. Med. Sci. Sports 2010, 22, 240–248. [Google Scholar] [CrossRef] [PubMed]
  178. Laplante, M.; Sabatini, D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122, 3589–3594. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  179. Weihrauch, M.; Handschin, C. Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls. Biochem. Pharmacol. 2017, 147, 211–220. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  180. Herzig, S.; Shaw, R. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 2018, 19, 121–135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  181. Hardie, G.; Schaffer, B.; Brunet, A. AMPK: An energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 2016, 26, 190–201. [Google Scholar] [CrossRef] [Green Version]
  182. Combes, A.; Dekerle, J.; Webborn, N.; Watt, P.; Bougault, V.; Daussin, F. Exercise-induced metabolic fluctuations influence AMPK, p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol. Rep. 2015, 3, e12462. [Google Scholar] [CrossRef]
  183. Chalari, E.; Methenitis, S.; Arnaoutis, G.; Stergiou, I.; Kampouropoulou, C.; Karampelas, E.; Prousinoudi, N.; Argyropoulou, V.; Nomikos, T. Different Kinetics of Oxidative Stress and Inflammatory Markers after Eccentric Exercise in Upper and Lower Limbs. Proceedings 2019, 25, 17. [Google Scholar] [CrossRef] [Green Version]
  184. Franz, A.; Behringer, M.; Nosaka, K.; Buhren, B.; Schrumpf, H.; Mayer, C.; Zilkens, C.; Schumann, M. Mechanisms underpinning protection against eccentric exercise-induced muscle damage by ischemic preconditioning. Med. Hypotheses 2017, 98, 21–27. [Google Scholar] [CrossRef]
  185. Chen, T.; Tseng, W.; Huang, G.; Chen, H.; Tseng, K.; Nosaka, K. Superior Effects of Eccentric to Concentric Knee Extensor Resistance Training on Physical Fitness, Insulin Sensitivity and Lipid Profiles of Elderly Men. Front. Physiol. 2017, 8. [Google Scholar] [CrossRef] [Green Version]
  186. Tajra, V.; Tibana, R.; Vieira, D.; De Farias, D.; Teixeira, T.; Funghetto, S.; Silva, A.; De Sousa, N.; Willardson, J.; Karnikowski, M. Identification of high responders for interleukin-6 and creatine kinase following acute eccentric resistance exercise in elderly obese women. J. Sci. Med. Sport 2014, 17, 662–666. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  187. Franchi, M.; Atherton, P.; Reeves, N.; Flück, M.; Williams, J.; Mitchell, W.; Selby, A.; Valls, R.B.; Narici, M. Architectural, functional and molecular responses to concentric and eccentric loading in human skeletal muscle. Acta Physiol. 2014, 210, 642–654. [Google Scholar] [CrossRef] [PubMed]
  188. Paschalis, V.; Nikolaidis, M.; Theodorou, A.; Panayiotou, G.; Fatouros, I.; Koutedakis, Y.; Jamurtas, A. A weekly bout of eccentric exercise is sufficient to induce health-promoting effects. Med. Sci. Sports Exerc. 2011, 43, 64–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  189. Chen, T.; Lin, K.; Chen, H.; Lin, M.; Nosaka, K. Comparison in eccentric exercise-induced muscle damage among four limb muscles. Eur. J. Appl. Physiol. 2011, 111, 211–223. [Google Scholar] [CrossRef] [PubMed]
  190. Paschalis, V.; Nikolaidis, M.; Theodorou, A.; Giakas, G.; Jamurtas, A.; Koutedakis, Y. Eccentric exercise affects the upper limbs more than the lower limbs in position sense and reaction angle. J. Sports Sci. 2010, 28, 33–43. [Google Scholar] [CrossRef]
  191. Paschalis, V.; Nikolaidis, M.; Giakas, G.; Theodorou, A.; Sakellariou, G.; Fatouros, I.; Koutedakis, Y.; Jamurtas, A. Beneficial changes in energy expenditure and lipid profile after eccentric exercise in overweight and lean women. Scand. J. Med. Sci. Sports 2010, 20, e103–e111. [Google Scholar] [CrossRef]
  192. Saka, T.; Akova, B.; Yazici, Z.; Sekir, U.; Gür, H.; Ozarda, Y. Difference in the magnitude of muscle damage between elbow flexors and knee extensors eccentric exercises. J. Sports Sci. Med. 2009, 8, 107–115. [Google Scholar]
  193. Mahoney, D.J.; Safdar, A.; Parise, G.; Melov, S.; Fu, M.; MacNeil, L.; Kaczor, J.; Payne, E.; Tarnopolsky, M. Gene expression profiling in human skeletal muscle during recovery from eccentric exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294, R1901–R1910. [Google Scholar] [CrossRef] [Green Version]
  194. Jamurtas, A.; Theocharis, V.; Tofas, T.; Tsiokanos, A.; Yfanti, C.; Paschalis, V.; Koutedakis, Y.; Nosaka, K. Comparison between leg and arm eccentric exercises of the same relative intensity on indices of muscle damage. Eur. J. Appl. Physiol. 2005, 95, 179–185. [Google Scholar] [CrossRef]
  195. Feasson, L.; Stockholm, D.; Freyssenet, D.; Richard, I.; Duguez, S.; Beckmann, J.; Denis, C. Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. J. Physiol. 2002, 543, 297–306. [Google Scholar] [CrossRef]
  196. Fatouros, I.; Jamurtas, A.; Nikolaidis, M.G.; Destouni, A.; Michailidis, Y.; Vrettou, C.; Douroudos, I.; Avloniti, A.; Chatzinikolaou, A.; Taxildaris, K. Time of sampling is crucial for measurement of cell-free plasma DNA following acute aseptic inflammation induced by exercise. Clin. Biochem. 2010, 43, 1368–1370. [Google Scholar] [CrossRef] [PubMed]
  197. Margaritelis, N.; Theodorou, A.; Paschalis, V.; Veskoukis, A.; Dipla, K.; Zafeiridis, A.; Panayiotou, G.; Vrabas, I.; Kyparos, A.; Nikolaidis, M. Experimental verification of regression to the mean in Redox Biol.: Differential responses to exercise. Free Radic. Res. 2016, 50, 1237–1244. [Google Scholar] [CrossRef] [PubMed]
  198. Nikolaidis, M.; Jamurtas, A.Z. Blood as a reactive species generator and redox status regulator during exercise. Arch. Biochem. Biophys. 2009, 490, 77–84. [Google Scholar] [CrossRef] [PubMed]
  199. Nikolaidis, M.; Paschalis, V.; Giakas, G.; Fatouros, I.; Sakellariou, G.; Theodorou, A.; Koutedakis, Y.; Jamurtas, A. Favorable and prolonged changes in blood lipid profile after muscle-damaging exercise. Med. Sci. Sports Exerc. 2008, 40, 1483–1489. [Google Scholar] [CrossRef] [PubMed]
  200. Sakelliou, A.; Fatouros, I.; Athanailidis, I.; Tsoukas, D.; Chatzinikolaou, A.; Draganidis, D.; Jamurtas, A.; Liacos, C.; Papassotiriou, I.; Mandalidis, D. Evidence of a redox-dependent regulation of immune responses to exercise-induced inflammation. Oxidative Med. Cell. Longev. 2016, 2016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  201. Higbie, E.J.; Cureton, K.J.; Warren, G.L.; Prior, B.M. Effects of concentric and eccentric training on muscle strength, cross-sectional area, and neural activation. J. Appl. Physiol. 1996, 81, 2173–2181. [Google Scholar] [CrossRef] [Green Version]
  202. Vikne, H.; Refsnes, P.E.; Ekmark, M.; Medbø, J.I.; Gundersen, V.; Gundersen, K. Muscular performance after concentric and eccentric exercise in trained men. Med. Sci. Sports Exerc. 2006, 38, 1770–1781. [Google Scholar] [CrossRef]
  203. Roig, M.; O’Brien, K.; Kirk, G.; Murray, R.; McKinnon, P.; Shadgan, B.; Reid, D.W. The effects of eccentric versus concentric resistance training on muscle strength and mass in healthy adults: A systematic review with meta-analyses. Br. J. Sports Med. 2009, 43, 556–568. [Google Scholar] [CrossRef]
  204. Nickols-Richardson, S.M.; Miller, L.E.; Wootten, D.F.; Ramp, W.K.; Herbert, W.G. Concentric and eccentric isokinetic resistance training similarly increases muscular strength, fat-free soft tissue mass, and specific bone mineral measurements in young women. Osteoporos. Int. 2007, 18, 789–796. [Google Scholar] [CrossRef]
  205. Walker, S.; Blazevich, A.J.; Haff, G.G.; Tufano, J.J.; Newton, R.U.; Häkkinen, K. Greater Strength Gains after Training with Accentuated Eccentric than Traditional Isoinertial Loads in Already Strength-Trained Men. Front. Physiol. 2016, 7. [Google Scholar] [CrossRef] [Green Version]
  206. Mike, J.; Cole, N.; Herrera, C.; VanD’usseldorp, T.; Kravitz, L.; Kerksick, C. The Effects of Eccentric Contraction Duration on Muscle Strength, Power Production, Vertical Jump, and Soreness. J. Strength Cond. Res. 2017, 31, 773–786. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  207. LaStayo, P.; Marcus, R.; Dibble, L.; Frajacomo, F.; Lindstedt, S. Eccentric exercise in rehabilitation: Safety, feasibility, and application. J. Appl. Physiol. 2014, 116, 1426–1434. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  208. Andersen, L.L.; Zeeman, P.; Jørgensen, J.R.; Bech-Pedersen, D.T.; Sørensen, J.; Kjær, M.; Andersen, J.L. Effects of intensive physical rehabilitation on neuromuscular adaptations in adults with poststroke hemiparesis. J. Strength Cond. Res. 2011, 25, 2808–2817. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  209. Mitchell, K.; Taivassalo, T.; Narici, M.; Franchi, M. Eccentric Exercise and the Critically ILL Patient. Front. Physiol. 2017, 8, 120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  210. Okamoto, T.; Masuhara, M.; Ikuta, K. Effects of eccentric and concentric resistance training on arterial stiffness. J. Hum. Hypertens. 2006, 20, 348–354. [Google Scholar] [CrossRef]
  211. Melo, R.C.; Quitério, R.J.; Takahashi, A.C.; Silva, E.; Martins, L.; Catai, A.M. High eccentric strength training reduces heart rate variability in healthy older men. Br. J. Sports Med. 2008, 42, 59–63. [Google Scholar] [CrossRef]
  212. Dos Santos, E.S.; Asano, R.Y.; Filho, G.I.; Lopes, N.L.; Panelli, P.; Nascimento, D.; Collier, S.R.; Prestes, J. Acute and chronic cardiovascular response to 16 weeks of combined eccentric or traditional resistance and aerobic training in elderly hypertensive women: A randomized controlled trial. J. Strength Cond. Res. 2014, 28, 3073–3084. [Google Scholar] [CrossRef]
  213. Takahashi, A.C.; Melo, R.C.; Quitério, R.J.; Silva, E.; Catai, A.M. The effect of eccentric strength training on heart rate and on its variability during isometric exercise in healthy older men. Eur. J. Appl. Physiol. 2009, 105, 315–323. [Google Scholar] [CrossRef]
  214. Hawkins, S.; Schroeder, T.; Wiswell, R.; Jaque, V.; Marcell, T.; Costa, K. Eccentric muscle action increases site-specific osteogenic response. Med. Sci. Sports Exerc. 1999, 31, 1287–1292. [Google Scholar] [CrossRef]
  215. Mueller, M.; Breil, F.A.; Vogt, M.; Steiner, R.; Lippuner, K.; Popp, A.; Klossner, S.; Hoppeler, H.; Däpp, C. Different response to eccentric and concentric training in older men and women. Eur. J. Appl. Physiol. 2009, 107, 145–153. [Google Scholar] [CrossRef] [Green Version]
  216. Leszczak, T.J.; Olson, J.M.; Stafford, J.; Di Brezzo, R. Early adaptations to eccentric and high-velocity training on strength and functional performance in community-dwelling older adults. J. Strength Cond. Res. 2013, 27, 442–448. [Google Scholar] [CrossRef]
  217. Selva Raj, I.; Bird, S.; Westfold, B.; Shield, A. Effects of eccentrically biased versus conventional weight training in older adults. Med. Sci. Sports Exerc. 2012, 44, 1167–1176. [Google Scholar] [CrossRef] [Green Version]
  218. Marcus, R.L.; Smith, S.; Morrell, G.; Addison, O.; Dibble, L.E.; Wahoff-Stice, D.; LaStayo, P.C. Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with type 2 diabetes mellitus. J. Phys. Ther. 2008, 88, 1345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  219. Casillas, J.M.; Besson, D.; Hannequin, A.; Gremeaux, V.; Morisset, C.; Tordi, N.; Laurent, Y.; Laroche, D. Effects of an eccentric training personalized by a low rate of perceived exertion on the maximal capacities in chronic heart failure. Eur. J. Phys. Rehabil. Med. 2015, 52, 159–168. [Google Scholar] [PubMed]
  220. Besson, D.; Joussain, C.; Gremeaux, V.; Morisset, C.; Laurent, Y.; Casillas, J.M.; Laroche, D. Eccentric training in chronic heart failure: Feasibility and functional effects. Results of a comparative study. Ann. Phys. Rehabil. Med. 2013, 56, 30–40. [Google Scholar] [CrossRef] [Green Version]
  221. Karagiannis, C.; Savva, C.; Mamais, I.; Efstathiou, M.; Monticone, M.; Xanthos, T. Eccentric exercise in ischemic cardiac patients and functional capacity: A systematic review and meta-analysis of randomized controlled trials. Ann. Phys. Rehabil. Med. 2016, 60, 58–64. [Google Scholar] [CrossRef]
  222. Lastayo, P.C.; Reich, T.E.; Urquhart, M.; Hoppeler, H.; Lindstedt, S.L. Chronic eccentric exercise: Improvements in muscle strength can occur with little demand for oxygen. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999, 276, R611–R615. [Google Scholar] [CrossRef]
  223. Bridgeman, L.; Gill, N.; Dulson, D.; McGuigan, M. The Effect of Exercise-Induced Muscle Damage After a Bout of Accentuated Eccentric Load Drop Jumps and the Repeated Bout Effect. J. Strength Cond. Res. 2017, 31, 386–394. [Google Scholar] [CrossRef]
  224. Skurvydas, A.; Brazaitis, M.; Venckūnas, T.; Kamandulis, S. Predictive value of strength loss as an indicator of muscle damage across multiple drop jumps. Appl. Physiol. Nutr. Metab. 2011, 36, 353–360. [Google Scholar] [CrossRef]
  225. Howatson, G.; Hoad, M.; Goodall, S.; Tallent, J.; Bell, P.; French, D. Exercise-induced muscle damage is reduced in resistance-trained males by branched chain amino acids: A randomized, double-blind, placebo controlled study. J. Int. Soc. Sports Nutr. 2012, 9, 20. [Google Scholar] [CrossRef] [Green Version]
  226. Tee, J.; Bosch, A.; Lambert, M. Metabolic Consequences of Exercise-Induced Muscle Damage. Sports Med. 2007, 37, 827–836. [Google Scholar] [CrossRef] [PubMed]
  227. Tofas, T.; Jamurtas, A.; Fatouros, I.; Nikolaidis, M.; Koutedakis, Y.; Sinouris, E.; Papageorgakopoulou, N.; Theocharis, D. Plyometric Exercise Increases Serum Indices of Muscle Damage and Collagen Breakdown. J. Strength Cond. Res. 2008, 22, 490–496. [Google Scholar] [CrossRef] [PubMed]
  228. Chatzinikolaou, A.; Fatouros, I.; Gourgoulis, V.; Avloniti, A.; Jamurtas, A.; Nikolaidis, M.; Douroudos, I.; Michailidis, Y.; Beneka, A.; Malliou, P. Time course of changes in performance and inflammatory responses after acute plyometric exercise. J. Strength Cond. Res. 2010, 24, 1389–1398. [Google Scholar] [CrossRef] [PubMed]
  229. Komi, P.V. Stretch-shortening cycle: A powerful model to study normal and fatigued muscle. J. Biomech. 2000, 33, 1197–1206. [Google Scholar] [CrossRef] [Green Version]
  230. Peake, J.; Suzuki, K.; Hordern, M.; Wilson, G.; Nosaka, K.; Coombes, J. Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur. J. Appl. Physiol. 2005, 95, 514–521. [Google Scholar] [CrossRef] [PubMed]
  231. Marklund, P.; Mattsson, M.; Wåhlin-Larsson, B.; Ponsot, E.; Lindvall, B.; Lindvall, L.; Ekblom, B.; Kadi, F. Extensive inflammatory cell infiltration in human skeletal muscle in response to an ultraendurance exercise bout in experienced athletes. J. Appl. Physiol. 2013, 114, 66–72. [Google Scholar] [CrossRef] [Green Version]
  232. Peñailillo, L.; Blazevich, A.; Numazawa, H.; Nosaka, K. Metabolic and Muscle Damage Profiles of Concentric versus Repeated Eccentric Cycling. Med. Sci. Sports Exerc. 2013, 45, 1773–1781. [Google Scholar] [CrossRef]
  233. Nieman, D.; Davis, M.; Henson, D.; Gross, S.; Dumke, C.; Utter, A.; Vinci, D.; Carson, J.; Brown, A.; Mcanulty, S.; et al. Muscle Cytokine mRNA Changes after 2.5 h of Cycling: Influence of Carbohydrate. Med. Sci. Sports Exerc. 2005, 37, 1283–1290. [Google Scholar] [CrossRef]
  234. González-Bartholin, R.; Mackay, K.; Valladares, D.; Zbinden-Foncea, H.; Nosaka, K.; Peñailillo, L. Changes in oxidative stress, inflammation and muscle damage markers following eccentric versus concentric cycling in older adults. Eur. J. Appl. Physiol. 2019, 119, 2301–2312. [Google Scholar] [CrossRef]
  235. Li, T.L.; Cheng, P.Y. Alterations of immunoendocrine responses during the recovery period after acute prolonged cycling. Eur. J. Appl. Physiol. 2007, 101, 539. [Google Scholar] [CrossRef]
  236. Kawanishi, N.; Kato, K.; Takahashi, M.; Mizokami, T.; Otsuka, Y.; Imaizumi, A.; Shiva, D.; Yano, H.; Suzuki, K. Curcumin attenuates oxidative stress following downhill running-induced muscle damage. Biochem. Biophys. Res. Commun. 2013, 441, 573–578. [Google Scholar] [CrossRef]
  237. Peake, J.; Suzuki, K.; Wilson, G.; Hordern, M.; Nosaka, K.; Mackinnon, L.; Coombes, J. Exercise-Induced Muscle Damage, Plasma Cytokines, and Markers of Neutrophil Activation. Med. Sci. Sports Exerc. 2005, 37, 737–745. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  238. Park, K.; Lee, M. Effects of unaccustomed downhill running on muscle damage, oxidative stress, and leukocyte apoptosis. J. Exerc. Nutr. Biochem. 2015, 19, 55–63. [Google Scholar] [CrossRef] [PubMed]
  239. Maeo, S.; Ando, Y.; Kanehisa, H.; Kawakami, Y. Localization of damage in the human leg muscles induced by downhill running. Sci. Rep. 2017, 7, 5769. [Google Scholar] [CrossRef] [Green Version]
  240. Malm, C.; Sjödin, B.; Sjöberg, B.; Lenkei, R.; Renström, P.; Lundberg, I.; Ekblom, B. Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J. Physiol. 2004, 556, 983–1000. [Google Scholar] [CrossRef]
  241. Damas, F.; Libardi, C.; Ugrinowitsch, C. The development of skeletal muscle hypertrophy through resistance training: The role of muscle damage and muscle protein synthesis. Eur. J. Appl. Physiol. 2018, 118, 485–500. [Google Scholar] [CrossRef]
  242. Damas, F.; Phillips, S.; Libardi, C.; Vechin, F.; Lixandrão, M.; Jannig, P.; Costa, L.; Bacurau, A.; Snijders, T.; Parise, G. Resistance training-induced changes in integrated myofibrillar protein synthesis are related to hypertrophy only after attenuation of muscle damage. J. Physiol. 2016, 594, 5209–5222. [Google Scholar] [CrossRef] [Green Version]
  243. Damas, F.; Ugrinowitsch, C.; Libardi, C.; Jannig, P.; Hector, A.; McGlory, C.; Lixandrão, M.; Vechin, F.; Montenegro, H.; Tricoli, V. Resistance training in young men induces muscle transcriptome-wide changes associated with muscle structure and metabolism refining the response to exercise-induced stress. Eur. J. Appl. Physiol. 2018, 118, 2607–2616. [Google Scholar] [CrossRef]
  244. Prestes, J.; Pereira, G.; Tibana, R.; Navalta, J. The acute response of apoptosis and migration to resistance exercise is protocol-dependent. Int. J. Sports Med. 2014, 35, 1051–1056. [Google Scholar] [CrossRef]
  245. Brown, W.; Davison, G.; McClean, C.; Murphy, M. A Systematic Review of the Acute Effects of Exercise on Immune and Inflammatory Indices in Untrained Adults. Sports Med. Open 2015, 1, 35. [Google Scholar] [CrossRef] [Green Version]
  246. Calle, M.; Fernandez, M. Effects of resistance training on the inflammatory response. Nutr. Res. Pract. 2010, 4, 259–269. [Google Scholar] [CrossRef] [Green Version]
  247. Cerqueira, É.; Marinho, D.; Neiva, H.; Lourenço, O. Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review. Front. Physiol. 2020, 10. [Google Scholar] [CrossRef] [PubMed]
  248. Della Gatta, P.; Cameron-Smith, D.; Peake, J. Acute resistance exercise increases the expression of chemotactic factors within skeletal muscle. Eur. J. Appl. Physiol. 2014, 114, 2157–2167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  249. Koh, T.; Pizza, F.X. Do inflammatory cells influence skeletal muscle hypertrophy? Front. Biosci. 2009, E1, 60–71. [Google Scholar]
  250. Ihalainen, J.; Walker, S.; Paulsen, G.; Häkkinen, K.; Kraemer, W.; Hämäläinen, M.; Vuolteenaho, K.; Moilanen, E.; Mero, A. Acute leukocyte, cytokine and adipocytokine responses to maximal and hypertrophic resistance exercise bouts. Eur. J. Appl. Physiol. 2014, 114, 2607–2616. [Google Scholar] [CrossRef] [PubMed]
  251. Miles, M.; Kraemer, W.; Nindl, B.; Grove, D.; Leach, S.; Dohi, K.; Marx, J.; Volek, J.; Mastro, A. Strength, workload, anaerobic intensity and the immune response to resistance exercise in women. Acta Physiol. 2003, 178, 155–163. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  252. Mitchell, C.J.; Churchward-Venne, T.A.; Bellamy, L.; Parise, G.; Baker, S.K.; Phillips, S. Muscular and systemic correlates of resistance training-induced muscle hypertrophy. PLoS ONE 2013, 8, e78636. [Google Scholar] [CrossRef] [Green Version]
  253. Vissing, K.; Overgaard, K.; Nedergaard, A.; Fredsted, A.; Schjerling, P. Effects of concentric and repeated eccentric exercise on muscle damage and calpain–calpastatin gene expression in human skeletal muscle. Eur. J. Appl. Physiol. 2008, 103, 323–332. [Google Scholar] [CrossRef]
  254. Hyldahl, R.; Olson, T.; Welling, T.; Groscost, L.; Parcell, A. Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise. Front. Physiol. 2014, 5. [Google Scholar] [CrossRef] [Green Version]
  255. Newton, M.; Morgan, G.; Sacco, P.; Chapman, D.; Nosaka, K. Comparison of Responses to Strenuous Eccentric Exercise of the Elbow Flexors Between Resistance-Trained and Untrained Men. J. Strength Cond. Res. 2008, 22, 597–607. [Google Scholar] [CrossRef] [Green Version]
  256. Margaritelis, N.; Theodorou, A.; Chatzinikolaou, P.; Kyparos, A.; Nikolaidis, M.; Paschalis, V. Eccentric exercise per se does not affect muscle damage biomarkers: Early and late phase adaptations. Eur. J. Appl. Physiol. 2020. [Google Scholar] [CrossRef] [PubMed]
  257. Methenitis, S.; Karandreas, N.; Spengos, K.; Zaras, N.; Stasinaki, A.N.; Terzis, G. Muscle Fiber Conduction Velocity, Muscle Fiber Composition, and Power Performance. Med. Sci. Sports Exerc. 2016, 48, 1761–1771. [Google Scholar] [CrossRef] [PubMed]
  258. Methenitis, S.; Spengos, K.; Zaras, N.; Stasinaki, A.N.; Papadimas, G.; Karampatsos, G.; Arnaoutis, G.; Terzis, G. Fiber Type Composition And Rate Of Force Development In Endurance And Resistance Trained Individuals. J. Strength Cond. Res. 2019, 33, 2388–2397. [Google Scholar] [CrossRef] [PubMed]
  259. Methenitis, S.; Zaras, N.; Spengos, K.; Stasinaki, A.N.; Karampatsos, G.; Georgiadis, G.; Terzis, G. Role of Muscle Morphology in Jumping, Sprinting, and Throwing Performance in Participants With Different Power Training Duration Experience. J. Strength Cond. Res. 2016, 30, 807–817. [Google Scholar] [CrossRef]
  260. Spiliopoulou, P.; Zaras, N.; Methenitis, S.; Papadimas, G.; Papadopoulos, C.; Bogdanis, G.; Terzis, G. The effect of concurrent power training and high intensity interval cycling on muscle morphology and performance. J. Strength Cond. Res. 2019. [Google Scholar] [CrossRef]
  261. Terzis, G.; Spengos, K.; Methenitis, S.; Aagaard, P.; Karandreas, N.; Bogdanis, G. Early phase interference between low-intensity running and power training in moderately trained females. Eur. J. Appl. Physiol. 2016, 116, 1063–1073. [Google Scholar] [CrossRef]
  262. Zacharia, E.; Spiliopoulou, P.; Methenitis, S.; Stasinaki, A.N.; Zaras, N.; Papadopoulos, C.; Papadimas, G.; Karampatsos, G.; Bogdanis, G.; Terzis, G. Changes in muscle power and muscle morphology with different volumes of fast eccentric half-squats. Sports 2019, 7, 164. [Google Scholar] [CrossRef] [Green Version]
  263. Zaras, N.; Spengos, K.; Methenitis, S.; Papadopoulos, C.; Karampatsos, G.; Georgiadis, G.; Stasinaki, A.N.; Manta, P.; Terzis, G. Effects of Strength vs. Ballistic-Power Training on Throwing Performance. J. Sports Sci. Med. 2013, 12, 130–137. [Google Scholar]
  264. Abramowitz, M.W.P.; Zhang, K.; Brightwell, K.; Newsom, J.; Kwon, K.; Custodio, M.; Buttar, R.; Farooq, H.; Zaidi, B. Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease. Am. J. Physiol. Ren. Physiol. 2018, 315, F1658–F1669. [Google Scholar] [CrossRef]
  265. Levinger, I.; Levinger, P.; Trenerry, M.; Feller, J.; Bartlett, J.; Bergman, N.; McKenna, M.; Cameron-Smith, D. Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum. 2011, 63, 1343–1348. [Google Scholar] [CrossRef]
  266. Caldow, M.; Cameron-Smith, D.; Levinger, P.; McKenna, M.; Levinger, I. Inflammatory markers in skeletal muscle of older adults. Eur. J. Appl. Physiol. 2013, 113, 509–517. [Google Scholar] [CrossRef] [PubMed]
  267. Deyhle, M.; Gier, A.; Evens, K.; Eggett, D.; Nelson, W.; Parcell, A.; Hyldahl, R. Skeletal muscle inflammation following repeated bouts of lengthening contractions in humans. Front. Physiol. 2016, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  268. Vella, L.; Markworth, J.; Paulsen, G.; Raastad, T.; Peake, J.; Snow, R.; Cameron-Smith, D.; Russell, A. Ibuprofen Ingestion Does Not Affect Markers of Post-exercise Muscle Inflammation. Front. Physiol. 2016, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  269. Stupka, N.; Tarnopolsky, M.; Yardley, N.; Phillips, S. Cellular adaptation to repeated eccentric exercise-induced muscle damage. J. Appl. Physiol. 2001, 91, 1669–1678. [Google Scholar] [CrossRef]
  270. Vella, L.; Markworth, J.; Farnfield, M.; Maddipati, K.; Russell, A.; Cameron-Smith, D. Intramuscular inflammatory and resolving lipid profile responses to an acute bout of resistance exercise in men. Physiol. Rep. 2019, 7, e14108. [Google Scholar] [CrossRef] [PubMed]
  271. Sag, E.; Kale, G.; Haliloglu, G.; Bilginer, Y.; Akcoren, Z.; Orhan, D.; Gucer, S.; Topaloglu, H.; Ozen, S.; Talim, B. Inflammatory milieu of muscle biopsies in juvenile dermatomyositis. Rheumatol. Int. 2020. [Google Scholar] [CrossRef] [PubMed]
  272. Singer, K.; Lumeng, C. The initiation of metabolic inflammation in childhood obesity. J. Clin. Investig. 2017, 127, 65–73. [Google Scholar] [CrossRef] [Green Version]
  273. Hyldahl, R.; Chen, T.; Nosaka, K. Mechanisms and Mediators of the Skeletal Muscle Repeated Bout Effect. Exerc. Sport Sci. Rev. 2017, 45, 24–33. [Google Scholar] [CrossRef] [PubMed]
  274. Sieljacks, P.; Matzon, A.; Wernbom, M.; Ringgaard, S.; Vissing, K.; Overgaard, K. Muscle damage and repeated bout effect following blood flow restricted exercise. Eur. J. Appl. Physiol. 2016, 116, 513–525. [Google Scholar] [CrossRef]
  275. Falvo, M.; Schilling, B.; Bloomer, R.; Smith, W. Repeated bout effect is absent in resistance trained men: An electromyographic analysis. J. Electromyogr. Kinesiol. 2009, 19, e529–e535. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  276. Mascher, H.; Tannerstedt, J.; Brink-Elfegoun, T.; Ekblom, B.; Gustafsson, T.; Blomstrand, E. Repeated resistance exercise training induces different changes in mRNA expression of MAFbx and MuRF-1 in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E43–E51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  277. O’Carroll, C.; Fenwick, R. Rhabdomyolysis: A case-based critical reflection on its causes and diagnosis. J. Emerg. Nurse 2020, 28. [Google Scholar] [CrossRef]
  278. Phillips, P.; Haas, R. Statin myopathy as a metabolic muscle disease. Expert Rev. Cardiovasc. Ther. 2008, 6, 971–978. [Google Scholar] [CrossRef] [PubMed]
  279. Camera, D.; Smiles, W.; Hawley, J. Exercise-induced skeletal muscle signaling pathways and human athletic performance. Free Radic. Biol. Med. 2016, 98, 131–143. [Google Scholar] [CrossRef] [PubMed]
  280. Radak, Z.; Bori, Z.; Koltai, E.; Fatouros, I.; Jamurtas, A.; Douroudos, I.; Terzis, G.; Nikolaidis, M.; Chatzinikolaou, A.; Sovatzidis, A. Age-dependent changes in 8-oxoguanine-DNA glycosylase activity are modulated by adaptive responses to physical exercise in human skeletal muscle. Free Radic. Biol. Med. 2011, 51, 417–423. [Google Scholar] [CrossRef] [Green Version]
  281. Powers, S.; Nelson, B.; Hudson, M. Exercise-induced oxidative stress in humans: Cause and consequences. Free Radic. Biol. Med. 2011, 51, 942–950. [Google Scholar] [CrossRef]
  282. Finaud, J.; Lac, G.; Filaire, E. Oxidative stress. Sports Med. 2006, 36, 327–358. [Google Scholar] [CrossRef]
  283. Radak, Z. Free Radicals in exeRcise and Aging; Human Kinetics Europe: Leeds, UK, 2000. [Google Scholar]
  284. Fehrenbach, E.; Northoff, H. Free radicals, exercise, apoptosis, and heat shock proteins. Exerc. Immunol. Rev. 2000, 7, 66–89. [Google Scholar]
  285. Brancaccio, P.; Lippi, G.; Maffulli, N. Biochemical markers of muscular damage. Clin. Chem. Lab. Med. 2010, 48, 757–767. [Google Scholar] [CrossRef]
  286. Wolfe, F.; Clauw, D.; Fitzcharles, M.; Goldenberg, D.; Häuser, W.; Katz, R.; Mease, P.; Russell, A.; Russell, I.; Walitt, B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 2016, 46, 319–329. [Google Scholar] [CrossRef]
  287. Atzeni, F.; Talotta, R.; Masala, I.; Giacomelli, C.; Conversano, C.; Nucera, V.; Lucchino, B.; Iannuccelli, C.; Di Franco, M.; Bazzichi, L. One year in review 2019: Fibromyalgia. Clin. Exp. Rheumatol. 2019, 37 (Suppl. 116), 3–10. [Google Scholar] [PubMed]
  288. Littlejohn, G.; Guymer, E. Neurogenic inflammation in fibromyalgia. Semin. Immunopathol. 2018, 40, 291–300. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Time course of the physiological responses during exercise-induced muscle damage.
Figure 1. Time course of the physiological responses during exercise-induced muscle damage.
Biomedicines 09 00036 g001
Figure 2. Methodological advantages of exercise-induced muscle damage.
Figure 2. Methodological advantages of exercise-induced muscle damage.
Biomedicines 09 00036 g002
Table 1. Clinical and biochemical indices affected by the inflammatory response after exercise-induced muscle damage.
Table 1. Clinical and biochemical indices affected by the inflammatory response after exercise-induced muscle damage.
Physiological ResponseMarker
Pain/Delayed Muscle SorenessPerceived Muscle Soreness by Visual Analog Scale or Algometers
Muscle FunctionRate of Force/Torque Development, Maximum Strength Power, Range of Motion, Muscular Work
OedemaLimb Circumferences
Oxidative StressProtein Carbonyls, MDA, Isoprostanes, GSH/GSSG, Antioxidant Enzymes (Glutathione Peroxidases, Superoxide Dismutase, Catalase), Total Antioxidant Capacity, Antioxidant Vitamins
Muscle DamageCK, LDH, Myoglobin, T-Troponin, Hydroxyproline, Hydroxylysine
Systemic InflammationWBC Count, IL-6, TNF-a, CRP, IL-10, IL-8, IL-1Ra, Lipid Mediators, INF-γ, MCP1, MIP-1
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Methenitis, S.; Stergiou, I.; Antonopoulou, S.; Nomikos, T. Can Exercise-Induced Muscle Damage Be a Good Model for the Investigation of the Anti-Inflammatory Properties of Diet in Humans? Biomedicines 2021, 9, 36. https://doi.org/10.3390/biomedicines9010036

AMA Style

Methenitis S, Stergiou I, Antonopoulou S, Nomikos T. Can Exercise-Induced Muscle Damage Be a Good Model for the Investigation of the Anti-Inflammatory Properties of Diet in Humans? Biomedicines. 2021; 9(1):36. https://doi.org/10.3390/biomedicines9010036

Chicago/Turabian Style

Methenitis, Spyridon, Ioanna Stergiou, Smaragdi Antonopoulou, and Tzortzis Nomikos. 2021. "Can Exercise-Induced Muscle Damage Be a Good Model for the Investigation of the Anti-Inflammatory Properties of Diet in Humans?" Biomedicines 9, no. 1: 36. https://doi.org/10.3390/biomedicines9010036

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop